Evaxion Biotech A/S(EVAX)

POST1.510.000.00%19:22 EDT

1.51-0.18-10.65%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
Evaxion Biotech A/S
Market
NASDAQ
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.evaxionbiotech.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.
- 04-01
  Annual Report
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 01-28
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 01-28
  [Amend]Public Prospectus
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-12-17
  [Amend]Public Prospectus
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-12-05
  [Amend]Public Prospectus
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-11-18
  Public Prospectus
  Form F-1 - Registration statement for certain foreign private issuers
  Form F-1 - Registration statement for certain foreign private issuers
- 2024-11-14
  Beneficial Ownership Change
  Form SC 13G - Statement of Beneficial Ownership by Certain Investors
  Form SC 13G - Statement of Beneficial Ownership by Certain Investors
- 2024-11-06
  Beneficial Ownership Change
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 2024-08-20
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-08-20
  [Amend]Public Prospectus
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-07-22
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-07-22
  [Amend]Public Prospectus
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-05-06
  Public Prospectus
  Form F-1 - Registration statement for certain foreign private issuers
  Form F-1 - Registration statement for certain foreign private issuers
- 2024-03-26
  Annual Report
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-01-31
  [Amend]Public Prospectus
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

1D
5D
Day
Week
Month

Loading ...

High

1.64

Open

1.63

Volume%

0.98

Low

1.50

1.69

T/O Rate

1.14%

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"pagemeta":{"title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evaxion Biotech A/S,EVAX,Evaxion Biotech A/S股票,Evaxion Biotech A/S股票老虎,Evaxion Biotech A/S股票老虎国际,Evaxion Biotech A/S行情,Evaxion Biotech A/S股票行情,Evaxion Biotech A/S股价,Evaxion Biotech A/S股市,Evaxion Biotech A/S股票价格,Evaxion Biotech A/S股票交易,Evaxion Biotech A/S股票购买,Evaxion Biotech A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"community","symbol":"EVAX","data":{"stockData":{"symbol":"EVAX","market":"US","secType":"STK","nameCN":"Evaxion Biotech A/S","latestPrice":1.51,"timestamp":1743796800000,"preClose":1.69,"halted":0,"volume":65947,"hourTrading":{"tag":"盘后","latestPrice":1.51,"preClose":1.51,"latestTime":"19:22 EDT","volume":171,"amount":266.15,"timestamp":1743808948565},"delay":0,"floatShares":5767000,"shares":6266572,"eps":-18.911705,"marketStatus":"Market Closed","change":-0.18,"latestTime":"04-04 16:00:00 EDT","open":1.63,"high":1.64,"low":1.5,"amount":101676.3789671,"amplitude":0.08284,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-18.911705,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":50,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":1.69,"preHourTrading":{"tag":"盘前","latestPrice":1.6886,"preClose":1.69,"latestTime":"09:27 EDT","volume":30,"amount":51.118002,"timestamp":1743773279332},"postHourTrading":{"tag":"盘后","latestPrice":1.51,"preClose":1.51,"latestTime":"19:22 EDT","volume":171,"amount":266.15,"timestamp":1743808948565},"volumeRatio":0.9782824758634994,"impliedVol":2.1042,"impliedVolPercentile":0},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.420795258020120","cardData":[{"tweetId":"420795258020120","author":{"authorId":"4193034873877942","idStr":"4193034873877942","name":"常清静","avatar":"https://static.tigerbbs.com/23d09c357eb251788dd0e849cb06b561","userType":1,"introduction":"","crmLevel":0,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":24,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/EVAX\">$Evaxion Biotech A/S(EVAX)$</a> 1","plainDigest":"$Evaxion Biotech A/S(EVAX)$ 1","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1743764258662,"gmtModify":1743764261005,"symbols":["EVAX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":13,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/420795258020120","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":26,"displayRows":2,"strategy":"timeline","authorId":"4193034873877942"}]},{"cardType":"TWEET","cardId":"TWEET.399995520839808","cardData":[{"tweetId":"399995520839808","author":{"authorId":"4195877729905992","idStr":"4195877729905992","name":"DodgeeMF","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":10,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://ttm.financial/S/EVAX\">$Evaxion Biotech A/S(EVAX)$ </a>&nbsp;","plainDigest":"$Evaxion Biotech A/S(EVAX)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1738680264966,"gmtModify":1738680344953,"symbols":["EVAX"],"themeIds":["7516f9ef7e8042739b8597466da26fe7"],"themes":[{"themeId":"7516f9ef7e8042739b8597466da26fe7","themeType":0,"name":"Winning Trades"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://community-static.tradeup.com/news/9bfd08db6ece7a78114b0aa4665a2c3a","width":"894","height":"1564"}],"repostCount":0,"viewCount":131,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/399995520839808","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":25,"displayRows":2,"strategy":"timeline","authorId":"4195877729905992"}]},{"cardType":"TWEET","cardId":"TWEET.399924620579472","cardData":[{"tweetId":"399924620579472","author":{"authorId":"4195877729905992","idStr":"4195877729905992","name":"DodgeeMF","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":10,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://ttm.financial/S/EVAX\">$Evaxion Biotech A/S(EVAX)$ </a>&nbsp;","plainDigest":"$Evaxion Biotech A/S(EVAX)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1738663335853,"gmtModify":1738663646215,"symbols":["EVAX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://community-static.tradeup.com/news/040a727dd99a79390bd6024c384dd8a0","width":"1080","height":"1759"}],"repostCount":0,"viewCount":66,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/399924620579472","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":25,"displayRows":2,"strategy":"timeline","authorId":"4195877729905992"}]},{"cardType":"TWEET","cardId":"TWEET.293305002422320","cardData":[{"tweetId":"293305002422320","author":{"authorId":"4118205146243860","idStr":"4118205146243860","name":"红运2022","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":31,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/EVAX\">$Evaxion Biotech A/S(EVAX)$ &nbsp;</a>","plainDigest":"$Evaxion Biotech A/S(EVAX)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1712627316395,"gmtModify":1712627320720,"symbols":["EVAX"],"themeIds":["7516f9ef7e8042739b8597466da26fe7"],"themes":[{"themeId":"7516f9ef7e8042739b8597466da26fe7","themeType":0,"name":"Winning Trades"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/52c5661133cc22d487f407df683805b5","width":"906","height":"1406"}],"repostCount":0,"viewCount":288,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/293305002422320","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":25,"displayRows":2,"strategy":"timeline","authorId":"4118205146243860"}]},{"cardType":"TWEET","cardId":"TWEET.293305182408904","cardData":[{"tweetId":"293305182408904","author":{"authorId":"4118205146243860","idStr":"4118205146243860","name":"红运2022","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":31,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/EVAX\">$Evaxion Biotech A/S(EVAX)$ &nbsp;</a>","plainDigest":"$Evaxion Biotech A/S(EVAX)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1712627241714,"gmtModify":1712627245094,"symbols":["EVAX"],"themeIds":["7516f9ef7e8042739b8597466da26fe7"],"themes":[{"themeId":"7516f9ef7e8042739b8597466da26fe7","themeType":0,"name":"Winning Trades"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/4bd565f7dee68372efff0ebe543fdb93","width":"906","height":"1406"}],"repostCount":0,"viewCount":226,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/293305182408904","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":25,"displayRows":2,"strategy":"timeline","authorId":"4118205146243860"}]},{"cardType":"TWEET","cardId":"TWEET.293126593421328","cardData":[{"tweetId":"293126593421328","author":{"authorId":"4118205146243860","idStr":"4118205146243860","name":"红运2022","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":31,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/EVAX\">$Evaxion Biotech A/S(EVAX)$ &nbsp;</a>","plainDigest":"$Evaxion Biotech A/S(EVAX)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1712583702624,"gmtModify":1712583706523,"symbols":["EVAX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/40f30b01824df52acc6842a1ca19f762","width":"1080","height":"2400"}],"repostCount":0,"viewCount":78,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/293126593421328","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":25,"displayRows":2,"strategy":"timeline","authorId":"4118205146243860"}]},{"cardType":"TWEET","cardId":"TWEET.290625588494624","cardData":[{"tweetId":"290625588494624","author":{"authorId":"3575780970872327","idStr":"3575780970872327","name":"TragikEnding","avatar":"https://static.tigerbbs.com/018a8f17c8edbe0284f4799c3d8e65b8","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":3,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"f00de38e20574ad1abf55a15966547c8-1","templateUuid":"f00de38e20574ad1abf55a15966547c8","name":"Average winning trade","description":"Top 50%","bigImgUrl":"https://community-static.tradeup.com/news/f53cdecfbff6499d133bad354ae10ff1","smallImgUrl":"https://community-static.tradeup.com/news/2554f84686bbcccc035b93fe29308e43","grayImgUrl":"https://community-static.tradeup.com/news/84c66bc70ac1cf09f4e89b1d4ca9d017","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.02","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://ttm.financial/S/EVAX\">$Evaxion Biotech A/S(EVAX)$</a> $7 soon","plainDigest":"$Evaxion Biotech A/S(EVAX)$ $7 soon","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1711979526163,"gmtModify":1711979635183,"symbols":["EVAX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://community-static.tradeup.com/news/c749e6490ed70f9ef0455431feaae568","width":"960","height":"2079"}],"repostCount":0,"viewCount":164,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/290625588494624","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":31,"displayRows":2,"strategy":"timeline","authorId":"3575780970872327"}]},{"cardType":"TWEET","cardId":"TWEET.267240252563640","cardData":[{"tweetId":"267240252563640","author":{"authorId":"4098523497474480","idStr":"4098523497474480","name":"Mukes","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://ttm.financial/S/EVAX\">$Evaxion Biotech A/S(EVAX)$</a>&nbsp;","plainDigest":"$Evaxion Biotech A/S(EVAX)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1706275454506,"gmtModify":1706277614355,"symbols":["EVAX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":70,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/267240252563640","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":25,"displayRows":2,"strategy":"timeline","authorId":"4098523497474480"}]},{"cardType":"TWEET","cardId":"TWEET.9950744896","cardData":[{"tweetId":"9950744896","author":{"authorId":"4109461531395300","idStr":"4109461531395300","name":"mars_venus","avatar":"https://community-static.tradeup.com/news/ea793d9d9a87db218b2f1749bf6ddfee","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":18,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://ttm.financial/S/EVAX\">$Evaxion Biotech A/S(EVAX)$ &nbsp;</a>[Call]&nbsp;[Call]&nbsp;[Call]&nbsp;","plainDigest":"$Evaxion Biotech A/S(EVAX)$ [Call] [Call] [Call]","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1672845264316,"gmtModify":1676538746794,"symbols":["EVAX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://community-static.tradeup.com/news/301a0fa48862cb7e535357285063054e","width":"1440","height":"2246"}],"repostCount":0,"viewCount":463,"likeCount":2,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/9950744896","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":43,"displayRows":2,"strategy":"timeline","authorId":"4109461531395300"}]},{"cardType":"TWEET","cardId":"TWEET.9950759935","cardData":[{"tweetId":"9950759935","author":{"authorId":"4109461531395300","idStr":"4109461531395300","name":"mars_venus","avatar":"https://community-static.tradeup.com/news/ea793d9d9a87db218b2f1749bf6ddfee","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":18,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"‌<a href=\"https://laohu8.com/S/EVAX\">$Evaxion Biotech A/S(EVAX)$ &nbsp;</a>‌rally please....","plainDigest":"‌$Evaxion Biotech A/S(EVAX)$ ‌rally please....","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1672842749927,"gmtModify":1676538746061,"symbols":["EVAX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":280,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/9950759935","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":42,"displayRows":2,"strategy":"timeline","authorId":"4109461531395300"}]},{"cardType":"TWEET","cardId":"TWEET.9913448201","cardData":[{"tweetId":"9913448201","author":{"authorId":"4095641161585110","idStr":"4095641161585110","name":"LordXin","avatar":"https://community-static.tradeup.com/news/758c3e75730b4eb0ddf838ab17a53e00","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.27","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://ttm.financial/S/EVAX\">$Evaxion Biotech A/S(EVAX)$</a>","plainDigest":"$Evaxion Biotech A/S(EVAX)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1664065225303,"gmtModify":1676537384092,"symbols":["EVAX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://community-static.tradeup.com/news/b07344020abc1db70573b3c66028d97d","width":"1080","height":"1920"}],"repostCount":0,"viewCount":1126,"likeCount":2,"liked":false,"collected":false,"commentCount":3,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/9913448201","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":25,"displayRows":2,"strategy":"timeline","authorId":"4095641161585110"}]},{"cardType":"TWEET","cardId":"TWEET.9919511198","cardData":[{"tweetId":"9919511198","author":{"authorId":"9000000000000137","idStr":"9000000000000137","name":"EdwardHughes","avatar":"https://static.tigerbbs.com/07bc9bca07cec671db72f7d6b853211d","userType":8,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":92,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"Evaxion's recent financial results are typical of a clinical stage biopharma in that they feature no revenue and significant R&amp;D and G&amp;A costs associated with its development efforts.The market opportunity for melanoma treatments is substantial and expected to grow markedly over the medium term.","plainDigest":"Evaxion's recent financial results are typical of a clinical stage biopharma in that they feature no revenue and significant R&D and G&A costs associated with its development efforts.The market opportunity for melanoma treatments is substantial and expected to grow markedly over the medium term.","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1663817831915,"gmtModify":1676537343220,"symbols":["EVAX"],"themeIds":["84ac2c57901b463da0573a608cc0b2a5"],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":350,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/9919511198","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":253,"displayRows":2,"strategy":"timeline","authorId":"9000000000000137"}]},{"cardType":"TWEET","cardId":"TWEET.9919513204","cardData":[{"tweetId":"9919513204","author":{"authorId":"9000000000000174","idStr":"9000000000000174","name":"KevinKelly","avatar":"https://static.tigerbbs.com/0965d3709fcccd732467fba87aa4ea6e","userType":8,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":219,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"Evaxion Biotech A/S is developing treatment candidates for various cancer conditions.According to a marketresearch reportby Grand View Research, the global market for melanoma therapeutics&nbsp;is expected to reach $11 billion by 2025.This represents a forecast CAGR (Compound Annual Growth Rate) of 11.21%.&nbsp;I&nbsp;hold&nbsp;for&nbsp;it.","plainDigest":"Evaxion Biotech A/S is developing treatment candidates for various cancer conditions.According to a marketresearch reportby Grand View Research, the global market for melanoma therapeutics is expected to reach $11 billion by 2025.This represents a forecast CAGR (Compound Annual Growth Rate) of 11.21%. I hold for it.","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1663817696709,"gmtModify":1676537343198,"symbols":["EVAX"],"themeIds":["84ac2c57901b463da0573a608cc0b2a5"],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":437,"likeCount":7,"liked":false,"collected":false,"commentCount":5,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/9919513204","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":272,"displayRows":2,"strategy":"timeline","authorId":"9000000000000174"}]},{"cardType":"TWEET","cardId":"TWEET.9056787852","cardData":[{"tweetId":"9056787852","author":{"authorId":"3573950263280521","idStr":"3573950263280521","name":"Holomatt","avatar":"https://static.tigerbbs.com/0fd601eb5c3a453ec63f7f732c8838ab","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":7,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"82ffa69a97264fba9002044f4f5f535b-1","templateUuid":"82ffa69a97264fba9002044f4f5f535b","name":"Tiger Think Tank","description":"Tiger Think Tank","bigImgUrl":"https://community-static.tradeup.com/news/193f8255673f42bdc610097b2074ec3e","smallImgUrl":"https://community-static.tradeup.com/news/06af124f59f026a383d35b268362424f","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.07","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":84,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://ttm.financial/S/EVAX\">$Evaxion Biotech A/S(EVAX)$</a>Hmmmmm...","plainDigest":"$Evaxion Biotech A/S(EVAX)$Hmmmmm...","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1655082855976,"gmtModify":1676535558055,"symbols":["EVAX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://community-static.tradeup.com/news/bf0caa7077fec47b7e202a7c1471e60b","width":"1170","height":"3702"}],"repostCount":0,"viewCount":151,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/9056787852","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":34,"displayRows":2,"strategy":"timeline","authorId":"3573950263280521"}]},{"cardType":"TWEET","cardId":"TWEET.9022130855","cardData":[{"tweetId":"9022130855","author":{"authorId":"3582448705299191","idStr":"3582448705299191","name":"PQ1991","avatar":"https://community-static.tradeup.com/news/adf91cfdc6879a4cf664d4a466376171","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://ttm.financial/S/EVAX\">$Evaxion Biotech A/S(EVAX)$</a>ssssssddd","plainDigest":"$Evaxion Biotech A/S(EVAX)$ssssssddd","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1653488108377,"gmtModify":1676535290966,"symbols":["EVAX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://community-static.tradeup.com/news/4891d609f9c0141871bd57d2244f2ebe","width":"1080","height":"2824"}],"repostCount":0,"viewCount":673,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/9022130855","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":34,"displayRows":2,"strategy":"timeline","authorId":"3582448705299191"}]},{"cardType":"TWEET","cardId":"TWEET.9022130362","cardData":[{"tweetId":"9022130362","author":{"authorId":"3582448705299191","idStr":"3582448705299191","name":"PQ1991","avatar":"https://community-static.tradeup.com/news/adf91cfdc6879a4cf664d4a466376171","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://ttm.financial/S/EVAX\">$Evaxion Biotech A/S(EVAX)$</a>sssaaassss","plainDigest":"$Evaxion Biotech A/S(EVAX)$sssaaassss","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1653488076657,"gmtModify":1676535290966,"symbols":["EVAX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://community-static.tradeup.com/news/dabb4950bd485e3c7d21c23c022fb85d","width":"1080","height":"2824"}],"repostCount":0,"viewCount":860,"likeCount":1,"liked":false,"collected":false,"commentCount":15,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":true,"shareLink":"https://ttm.financial/post/9022130362","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":35,"displayRows":2,"strategy":"timeline","authorId":"3582448705299191"}]},{"cardType":"TWEET","cardId":"TWEET.9065686121","cardData":[{"tweetId":"9065686121","author":{"authorId":"3586061751257522","idStr":"3586061751257522","name":"SlowIncome","avatar":"https://static.tigerbbs.com/8f58da85f59ba0a3ddf93647be45c630","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":1034,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"(10/05)Today's pre-market BOOMs:<a href=\"https://ttm.financial/S/BHVN\">$Biohaven Pharmaceutical Holding Co Ltd.(BHVN)$</a><a href=\"https://ttm.financial/S/VRM\">$Vroom, Inc.(VRM)$</a><a href=\"https://ttm.financial/S/EVAX\">$Evaxion Biotech A/S(EVAX)$</a><a href=\"https://ttm.financial/S/INM\">$InMed Pharmaceuticals Inc(INM)$</a><a href=\"https://ttm.financial/S/DRE\">$Duke(DRE)$</a>Do share your thoughts on today's symbols&nbsp;","plainDigest":"(10/05)Today's pre-market BOOMs:$Biohaven Pharmaceutical Holding Co Ltd.(BHVN)$$Vroom, Inc.(VRM)$$Evaxion Biotech A/S(EVAX)$$InMed Pharmaceuticals Inc(INM)$$Duke(DRE)$Do share your thoughts on today's symbols","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1652187864263,"gmtModify":1676535047893,"symbols":["VRM","BHVN","INM","DRE","EVAX"],"themeIds":["470d3ab575ca43caaed8156645b7ccbe"],"themes":[{"themeId":"470d3ab575ca43caaed8156645b7ccbe","themeType":0,"name":"💰 Stocks to watch today?(3 Apr)"}],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":334,"likeCount":6,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/9065686121","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":191,"displayRows":2,"strategy":"timeline","authorId":"3586061751257522"}]},{"cardType":"TWEET","cardId":"TWEET.9015562644","cardData":[{"tweetId":"9015562644","author":{"authorId":"4087704243448520","idStr":"4087704243448520","name":"carrots","avatar":"https://static.tigerbbs.com/c42ac514b7bae60da384f8f82a555127","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://ttm.financial/S/EVAX\">$Evaxion Biotech A/S(EVAX)$</a>sugar","plainDigest":"$Evaxion Biotech A/S(EVAX)$sugar","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1649514161257,"gmtModify":1676534523838,"symbols":["EVAX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://community-static.tradeup.com/news/c94ec2d0652329bda36b3cef5769d7a5","width":"1080","height":"2145"}],"repostCount":0,"viewCount":287,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/9015562644","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":30,"displayRows":2,"strategy":"timeline","authorId":"4087704243448520"}]}],"size":18,"extra":{"requestId":"74c7884e4c5f45498c259ec673d8a17f"}},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"19332996","market":"us","labels":[],"media":"sec.gov","original_id":"AN117184325001916-EVAX","pdf_url":"","pub_time":1743480000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"EVAX","title":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/0001171843-25-001916-index.htm","us_notice_code":"Form 20-F","us_title_en":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 20-F","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/evax20241231_20f.htm","primary":true,"translateUrl":"","linkName":"evax20241231_20f.htm","type":"20-F","id":"NTFILE1gj6EeB2CrAVYdiY","market":"us","size":5401475},{"description":"EXHIBIT 11.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/ex_797219.htm","primary":false,"translateUrl":"","linkName":"ex_797219.htm","type":"EX-11.1","id":"NTFILEExtkxmQPCExssq8v","market":"us","size":72755},{"description":"EXHIBIT 12.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/ex_797220.htm","primary":false,"translateUrl":"","linkName":"ex_797220.htm","type":"EX-12.1","id":"NTFILEER5p3Y5WweXwKBWi","market":"us","size":8487},{"description":"EXHIBIT 12.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/ex_797221.htm","primary":false,"translateUrl":"","linkName":"ex_797221.htm","type":"EX-12.2","id":"NTFILE8gvAVuXkMQsWHRRS","market":"us","size":8204},{"description":"EXHIBIT 13.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/ex_797222.htm","primary":false,"translateUrl":"","linkName":"ex_797222.htm","type":"EX-13.1","id":"NTFILE93F48uLMuGedBt9G","market":"us","size":3726},{"description":"EXHIBIT 13.2","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/ex_797223.htm","primary":false,"translateUrl":"","linkName":"ex_797223.htm","type":"EX-13.2","id":"NTFILE29Z4GbCTajpA7tfn","market":"us","size":3771},{"description":"EXHIBIT 15.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/ex_797224.htm","primary":false,"translateUrl":"","linkName":"ex_797224.htm","type":"EX-15.1","id":"NTFILE4259UnPqdT6XEUuX","market":"us","size":7429},{"description":"EXHIBIT 97.1","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/ex_797225.htm","primary":false,"translateUrl":"","linkName":"ex_797225.htm","type":"EX-97.1","id":"NTFILE5dzgiSUjxxHXeSaU","market":"us","size":27070},{"description":"","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/evaxionlogo.jpg","primary":false,"translateUrl":"","linkName":"evaxionlogo.jpg","type":"GRAPHIC","id":"NTFILEFNJTBwSafoU57mcT","market":"us","size":6533},{"description":"","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig2.jpg","primary":false,"translateUrl":"","linkName":"fig2.jpg","type":"GRAPHIC","id":"NTFILEHMKc14Kzg6rqgdKa","market":"us","size":63938},{"description":"","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig4a.jpg","primary":false,"translateUrl":"","linkName":"fig4a.jpg","type":"GRAPHIC","id":"NTFILE6LPpw5HrJgQCNvBQ","market":"us","size":85113},{"description":"","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig4b.jpg","primary":false,"translateUrl":"","linkName":"fig4b.jpg","type":"GRAPHIC","id":"NTFILEGXYaU5CPa1Hw6BRt","market":"us","size":79137},{"description":"","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig5.jpg","primary":false,"translateUrl":"","linkName":"fig5.jpg","type":"GRAPHIC","id":"NTFILECDuqSBaHzojJHu4X","market":"us","size":44135},{"description":"","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig6.jpg","primary":false,"translateUrl":"","linkName":"fig6.jpg","type":"GRAPHIC","id":"NTFILEAHbfa9XVBndBK9eM","market":"us","size":24131},{"description":"","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig7.jpg","primary":false,"translateUrl":"","linkName":"fig7.jpg","type":"GRAPHIC","id":"NTFILEGQyAUXeRBSC6Eesj","market":"us","size":35660},{"description":"","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig8.jpg","primary":false,"translateUrl":"","linkName":"fig8.jpg","type":"GRAPHIC","id":"NTFILEA2MYYGwebotLSgmF","market":"us","size":45212},{"description":"","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig9.jpg","primary":false,"translateUrl":"","linkName":"fig9.jpg","type":"GRAPHIC","id":"NTFILEEmTUowLEzisdJmCW","market":"us","size":43754},{"description":"","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig10.jpg","primary":false,"translateUrl":"","linkName":"fig10.jpg","type":"GRAPHIC","id":"NTFILEGzoRs613yCSFkEF3","market":"us","size":91348},{"description":"","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig11.jpg","primary":false,"translateUrl":"","linkName":"fig11.jpg","type":"GRAPHIC","id":"NTFILEChaGoKn6UKrKyMm2","market":"us","size":89953},{"description":"","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig12.jpg","primary":false,"translateUrl":"","linkName":"fig12.jpg","type":"GRAPHIC","id":"NTFILEBcyVD9RZKZRoQnpj","market":"us","size":22282},{"description":"","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig13.jpg","primary":false,"translateUrl":"","linkName":"fig13.jpg","type":"GRAPHIC","id":"NTFILE71SUMSfkdHaGCU4y","market":"us","size":28057},{"description":"","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig13b.jpg","primary":false,"translateUrl":"","linkName":"fig13b.jpg","type":"GRAPHIC","id":"NTFILE8gY8ofmK8K7KeU3T","market":"us","size":16521},{"description":"","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig14.jpg","primary":false,"translateUrl":"","linkName":"fig14.jpg","type":"GRAPHIC","id":"NTFILE9Pbn8RJUt6zhGvvC","market":"us","size":36026},{"description":"","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig15.jpg","primary":false,"translateUrl":"","linkName":"fig15.jpg","type":"GRAPHIC","id":"NTFILE6rPWhDP2U4Uiw3kT","market":"us","size":33677},{"description":"","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig16.jpg","primary":false,"translateUrl":"","linkName":"fig16.jpg","type":"GRAPHIC","id":"NTFILE64jgvHnnsXFVodpV","market":"us","size":50449},{"description":"","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig17.jpg","primary":false,"translateUrl":"","linkName":"fig17.jpg","type":"GRAPHIC","id":"NTFILEB7vkN8Vyh2w6Mj15","market":"us","size":19564},{"description":"","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig18.jpg","primary":false,"translateUrl":"","linkName":"fig18.jpg","type":"GRAPHIC","id":"NTFILE6QBPRgrR37tnwYUm","market":"us","size":67679},{"description":"","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig19a.jpg","primary":false,"translateUrl":"","linkName":"fig19a.jpg","type":"GRAPHIC","id":"NTFILEDe2MHpGSvgNSNQZe","market":"us","size":57015},{"description":"","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig19b.jpg","primary":false,"translateUrl":"","linkName":"fig19b.jpg","type":"GRAPHIC","id":"NTFILEGR2tQNqhJMbuVT1A","market":"us","size":52801},{"description":"","seq":35,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/fig20.jpg","primary":false,"translateUrl":"","linkName":"fig20.jpg","type":"GRAPHIC","id":"NTFILEFaC3Jk94odzRonEJ","market":"us","size":66207},{"description":"","seq":36,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/logo.jpg","primary":false,"translateUrl":"","linkName":"logo.jpg","type":"GRAPHIC","id":"NTFILECCj69oFJ8JBXwKuZ","market":"us","size":13672},{"description":"","seq":37,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/neoantigen.jpg","primary":false,"translateUrl":"","linkName":"neoantigen.jpg","type":"GRAPHIC","id":"NTFILEFpvWNMnCC4yDGKS8","market":"us","size":59272},{"description":"","seq":38,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/productdevelopment.jpg","primary":false,"translateUrl":"","linkName":"productdevelopment.jpg","type":"GRAPHIC","id":"NTFILE7n4CphWCsFroV152","market":"us","size":39604},{"description":"","seq":39,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/stratambition.jpg","primary":false,"translateUrl":"","linkName":"stratambition.jpg","type":"GRAPHIC","id":"NTFILE7zuJ3LnnfXU6k2xD","market":"us","size":37630},{"description":"","seq":40,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure20.jpg","primary":false,"translateUrl":"","linkName":"wfigure20.jpg","type":"GRAPHIC","id":"NTFILE8e3ptGaCbwVZRiUq","market":"us","size":34197},{"description":"","seq":41,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure21.jpg","primary":false,"translateUrl":"","linkName":"wfigure21.jpg","type":"GRAPHIC","id":"NTFILE37YY234jHcCRMqs6","market":"us","size":24857},{"description":"","seq":42,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure22.jpg","primary":false,"translateUrl":"","linkName":"wfigure22.jpg","type":"GRAPHIC","id":"NTFILE613SXVuWzwgu8kZ8","market":"us","size":55258},{"description":"","seq":43,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure23.jpg","primary":false,"translateUrl":"","linkName":"wfigure23.jpg","type":"GRAPHIC","id":"NTFILE6HG5hg9HdQZDR2VL","market":"us","size":54666},{"description":"","seq":44,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure24.jpg","primary":false,"translateUrl":"","linkName":"wfigure24.jpg","type":"GRAPHIC","id":"NTFILE5Etj4ov3CYZVm2JX","market":"us","size":37568},{"description":"","seq":45,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure25.jpg","primary":false,"translateUrl":"","linkName":"wfigure25.jpg","type":"GRAPHIC","id":"NTFILE9RdPGithcH9WRLHe","market":"us","size":34599},{"description":"","seq":46,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure26.jpg","primary":false,"translateUrl":"","linkName":"wfigure26.jpg","type":"GRAPHIC","id":"NTFILEfmn2cyzK3XziPT6y","market":"us","size":17032},{"description":"","seq":47,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure27.jpg","primary":false,"translateUrl":"","linkName":"wfigure27.jpg","type":"GRAPHIC","id":"NTFILEGZRdQfmqgJB2KBYJ","market":"us","size":39469},{"description":"","seq":48,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure28.jpg","primary":false,"translateUrl":"","linkName":"wfigure28.jpg","type":"GRAPHIC","id":"NTFILEEEg9z8rgFttDF5am","market":"us","size":35069},{"description":"","seq":49,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure29.jpg","primary":false,"translateUrl":"","linkName":"wfigure29.jpg","type":"GRAPHIC","id":"NTFILE7qvBwmjnXdRLe4Fj","market":"us","size":75601},{"description":"","seq":50,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure30.jpg","primary":false,"translateUrl":"","linkName":"wfigure30.jpg","type":"GRAPHIC","id":"NTFILEHBbaLwjZBfxPR2HU","market":"us","size":97670},{"description":"","seq":51,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure31.jpg","primary":false,"translateUrl":"","linkName":"wfigure31.jpg","type":"GRAPHIC","id":"NTFILE3HC5zws9vrv2acJj","market":"us","size":57034},{"description":"","seq":52,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure32.jpg","primary":false,"translateUrl":"","linkName":"wfigure32.jpg","type":"GRAPHIC","id":"NTFILE8ykpHJFGTDnW1x62","market":"us","size":40860},{"description":"","seq":53,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure33.jpg","primary":false,"translateUrl":"","linkName":"wfigure33.jpg","type":"GRAPHIC","id":"NTFILE6bs49jzLUUt6TxAc","market":"us","size":18876},{"description":"","seq":54,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure34.jpg","primary":false,"translateUrl":"","linkName":"wfigure34.jpg","type":"GRAPHIC","id":"NTFILE3ixESzfjeXmSJeMx","market":"us","size":20944},{"description":"","seq":55,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure35.jpg","primary":false,"translateUrl":"","linkName":"wfigure35.jpg","type":"GRAPHIC","id":"NTFILE3HtUw1Dm2Wh4z9W7","market":"us","size":18842},{"description":"","seq":56,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure36.jpg","primary":false,"translateUrl":"","linkName":"wfigure36.jpg","type":"GRAPHIC","id":"NTFILE6kk5Vn6LHs1Hekhx","market":"us","size":25243},{"description":"","seq":57,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure37.jpg","primary":false,"translateUrl":"","linkName":"wfigure37.jpg","type":"GRAPHIC","id":"NTFILE9c7JoAYBu7kA4fcW","market":"us","size":29777},{"description":"","seq":58,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure38.jpg","primary":false,"translateUrl":"","linkName":"wfigure38.jpg","type":"GRAPHIC","id":"NTFILEFortJdbzRLwRgHMR","market":"us","size":59749},{"description":"","seq":59,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure39.jpg","primary":false,"translateUrl":"","linkName":"wfigure39.jpg","type":"GRAPHIC","id":"NTFILEDxD4GjPDhJHkvrCW","market":"us","size":26353},{"description":"","seq":60,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure40.jpg","primary":false,"translateUrl":"","linkName":"wfigure40.jpg","type":"GRAPHIC","id":"NTFILE8HjGuLuP1AAKVbV4","market":"us","size":18966},{"description":"","seq":61,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure41.jpg","primary":false,"translateUrl":"","linkName":"wfigure41.jpg","type":"GRAPHIC","id":"NTFILE21T7r1y74VZoZyQA","market":"us","size":26848},{"description":"","seq":62,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure42.jpg","primary":false,"translateUrl":"","linkName":"wfigure42.jpg","type":"GRAPHIC","id":"NTFILEBHNSq421nty3p5VE","market":"us","size":46280},{"description":"","seq":63,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure43.jpg","primary":false,"translateUrl":"","linkName":"wfigure43.jpg","type":"GRAPHIC","id":"NTFILEEn4priTokdiB5Ar4","market":"us","size":55727},{"description":"","seq":64,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure44.jpg","primary":false,"translateUrl":"","linkName":"wfigure44.jpg","type":"GRAPHIC","id":"NTFILE595XFqk2VXDGskup","market":"us","size":39962},{"description":"","seq":65,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/wfigure45.jpg","primary":false,"translateUrl":"","linkName":"wfigure45.jpg","type":"GRAPHIC","id":"NTFILE6upyehUCrQKZu7GX","market":"us","size":18470}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Annual Report","pubTime":"2025-04-01 12:00","pubTimestamp":1743480000,"title_zh":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19179281","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925006763-EVAX","pdf_url":"","pub_time":1738102167000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"EVAX","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1828253/0001104659-25-006763-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006763/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEHAJEpE2dQxjbmKm8","market":"us","size":9967},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006763/tm2427973d9_correspimg001.jpg","primary":false,"translateUrl":"","linkName":"tm2427973d9_correspimg001.jpg","type":"GRAPHIC","id":"NTFILEHLMG6mZmQ9BnXNNC","market":"us","size":10597}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-01-29 06:09","pubTimestamp":1738102167,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19082994","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925006720-EVAX","pdf_url":"","pub_time":1738040400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","symbol":"EVAX","title":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/0001104659-25-006720-index.htm","us_notice_code":"Form F-1/A","us_title_en":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"F-1/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/tm2427973-7_f1a.htm","primary":true,"translateUrl":"","linkName":"tm2427973-7_f1a.htm","type":"F-1/A","id":"NTFILEDwhauwfnSg8xtK9A","market":"us","size":2382147},{"description":"EXHIBIT 1.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/tm2427973d8_ex1-1.htm","primary":false,"translateUrl":"","linkName":"tm2427973d8_ex1-1.htm","type":"EX-1.1","id":"NTFILEECAkyvmnitHknHY3","market":"us","size":99017},{"description":"EXHIBIT 10.18","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/tm2427973d8_ex10-18.htm","primary":false,"translateUrl":"","linkName":"tm2427973d8_ex10-18.htm","type":"EX-10.18","id":"NTFILEDyJVs349h7e6DDyU","market":"us","size":245001},{"description":"EXHIBIT 23.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/tm2427973d8_ex23-1.htm","primary":false,"translateUrl":"","linkName":"tm2427973d8_ex23-1.htm","type":"EX-23.1","id":"NTFILE9YiLbW8YcHd69nmU","market":"us","size":2219},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/bc_antibody-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_antibody-4c.jpg","type":"GRAPHIC","id":"NTFILEFGgic4nhnSDaLTR9","market":"us","size":20090},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/bc_bestranked-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_bestranked-4c.jpg","type":"GRAPHIC","id":"NTFILEJ7s2bCe8WK3PK4Sa","market":"us","size":36851},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/bc_changetrg-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_changetrg-4c.jpg","type":"GRAPHIC","id":"NTFILE7M8Z32QHvHZvVyMd","market":"us","size":51187},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/bc_killing-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_killing-4c.jpg","type":"GRAPHIC","id":"NTFILE7P3ZhTobbGFc1EJx","market":"us","size":65238},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/bc_patient-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_patient-4c.jpg","type":"GRAPHIC","id":"NTFILE5aQurF6uPUgd5aYE","market":"us","size":67682},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/bc_preexisting-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_preexisting-4c.jpg","type":"GRAPHIC","id":"NTFILEBVfPixfwJSFU1BKs","market":"us","size":81117},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/bc_sarsgenome-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_sarsgenome-4c.jpg","type":"GRAPHIC","id":"NTFILE4HYaGCSqJWNbMuY3","market":"us","size":38363},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/bc_sfupbmc-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_sfupbmc-4c.jpg","type":"GRAPHIC","id":"NTFILEHA8PiTx2GPfmEkNL","market":"us","size":83884},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/bc_splenocytes-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_splenocytes-4c.jpg","type":"GRAPHIC","id":"NTFILE2pAH11wmc8QsETqt","market":"us","size":38054},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_aiimmunology-4clr.jpg","primary":false,"translateUrl":"","linkName":"fc_aiimmunology-4clr.jpg","type":"GRAPHIC","id":"NTFILE6cddjTvaC5DH2rHe","market":"us","size":86486},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_cancer-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cancer-4c.jpg","type":"GRAPHIC","id":"NTFILECYKDyPWYdoYDGmjK","market":"us","size":60354},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_cancervaccines-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cancervaccines-4c.jpg","type":"GRAPHIC","id":"NTFILEBL4Zii8LQC4QsSUc","market":"us","size":38086},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_cd4cd8cells-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cd4cd8cells-4c.jpg","type":"GRAPHIC","id":"NTFILE8iJRtLvJrTYVtUsA","market":"us","size":74826},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_cells-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cells-4c.jpg","type":"GRAPHIC","id":"NTFILE3nCSFf2Aq3xBiKJS","market":"us","size":51252},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_datacuration-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_datacuration-4c.jpg","type":"GRAPHIC","id":"NTFILE8mpoFZMTrbNJHuLy","market":"us","size":55331},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_discovery-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_discovery-4c.jpg","type":"GRAPHIC","id":"NTFILEBPBJVQX3PzazMFr7","market":"us","size":160498},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_evx02-4clr.jpg","primary":false,"translateUrl":"","linkName":"fc_evx02-4clr.jpg","type":"GRAPHIC","id":"NTFILE44212sjY7L7dyBky","market":"us","size":95190},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_evxb1-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_evxb1-4c.jpg","type":"GRAPHIC","id":"NTFILEBCGtVRYdTFzAQePb","market":"us","size":62087},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_identification-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_identification-4c.jpg","type":"GRAPHIC","id":"NTFILEF6Y2fqZhXaFqvbRD","market":"us","size":82717},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_immun-bw.jpg","primary":false,"translateUrl":"","linkName":"fc_immun-bw.jpg","type":"GRAPHIC","id":"NTFILEDYndSHTJb2e56JkE","market":"us","size":95117},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_ngo265-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_ngo265-4c.jpg","type":"GRAPHIC","id":"NTFILE7TVacNwChRU5KCQ6","market":"us","size":174298},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_pioneerrna-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_pioneerrna-4c.jpg","type":"GRAPHIC","id":"NTFILEEwwtLvfeC3gU3eQw","market":"us","size":52253},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_proteins-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_proteins-4c.jpg","type":"GRAPHIC","id":"NTFILE2vqGkvmvRtspmqzv","market":"us","size":118887},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_screening-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_screening-4c.jpg","type":"GRAPHIC","id":"NTFILEAYdFEFb7dFFFEtim","market":"us","size":25983},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_stageofdevelop-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_stageofdevelop-4c.jpg","type":"GRAPHIC","id":"NTFILEDfV6p1xrVU7CDB3X","market":"us","size":80743},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_strategy-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_strategy-4c.jpg","type":"GRAPHIC","id":"NTFILE7cN3FUGYmqPwEvus","market":"us","size":132876},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_vaccinetreat-4clr.jpg","primary":false,"translateUrl":"","linkName":"fc_vaccinetreat-4clr.jpg","type":"GRAPHIC","id":"NTFILEEf7TcHte5tZAxNVc","market":"us","size":96229},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/fc_vehiclecontrol-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_vehiclecontrol-4c.jpg","type":"GRAPHIC","id":"NTFILEFLmDppMiNfZteQy8","market":"us","size":135671},{"description":"GRAPHIC","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_abcessarea-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_abcessarea-4c.jpg","type":"GRAPHIC","id":"NTFILEARquVCWBENeE3Jzi","market":"us","size":37776},{"description":"GRAPHIC","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_auccfu-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_auccfu-4c.jpg","type":"GRAPHIC","id":"NTFILE7PazXtGZHPAL74aA","market":"us","size":62059},{"description":"GRAPHIC","seq":35,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_bacteria-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_bacteria-4c.jpg","type":"GRAPHIC","id":"NTFILEA8Jej6jAKDKmMQGD","market":"us","size":154890},{"description":"GRAPHIC","seq":36,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_cellinoculation-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_cellinoculation-4c.jpg","type":"GRAPHIC","id":"NTFILEG8nBnbVE3vP7GPLh","market":"us","size":92243},{"description":"GRAPHIC","seq":37,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_clinical-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_clinical-4c.jpg","type":"GRAPHIC","id":"NTFILEAVQ2aneBu5nRYrXG","market":"us","size":106643},{"description":"GRAPHIC","seq":38,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_empty-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_empty-4c.jpg","type":"GRAPHIC","id":"NTFILE47crc4PsKAz4GdYp","market":"us","size":35955},{"description":"GRAPHIC","seq":39,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_emptyplasmid-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_emptyplasmid-4c.jpg","type":"GRAPHIC","id":"NTFILEr7BUKbVToh6kZ2ye","market":"us","size":73045},{"description":"GRAPHIC","seq":40,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_halfmaxtiter-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_halfmaxtiter-4c.jpg","type":"GRAPHIC","id":"NTFILE9ti62UuYFeBY7X4B","market":"us","size":21103},{"description":"GRAPHIC","seq":41,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_immunizations-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_immunizations-4c.jpg","type":"GRAPHIC","id":"NTFILE8eo3TBhK8RXf5ZJs","market":"us","size":25560},{"description":"GRAPHIC","seq":42,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_kidneys-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_kidneys-4c.jpg","type":"GRAPHIC","id":"NTFILE8rzdKGtxD2zswuFX","market":"us","size":24535},{"description":"GRAPHIC","seq":43,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_liuhugoanti-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_liuhugoanti-4c.jpg","type":"GRAPHIC","id":"NTFILE5zuvP6vNQBfcUEBb","market":"us","size":155237},{"description":"GRAPHIC","seq":44,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_neoagspearson-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_neoagspearson-4c.jpg","type":"GRAPHIC","id":"NTFILE3x63DtbGuYt4zuJv","market":"us","size":70888},{"description":"GRAPHIC","seq":45,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_pioneerscore-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_pioneerscore-bw.jpg","type":"GRAPHIC","id":"NTFILEDZ7y9EGdVMKnLv7Y","market":"us","size":45148},{"description":"GRAPHIC","seq":46,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_postinfection-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_postinfection-4c.jpg","type":"GRAPHIC","id":"NTFILE2C11g9UEyKZAcLva","market":"us","size":22562},{"description":"GRAPHIC","seq":47,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_postinfections-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_postinfections-4c.jpg","type":"GRAPHIC","id":"NTFILEDtQcgo7Sq34WFzn2","market":"us","size":277722},{"description":"GRAPHIC","seq":48,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_prepost-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_prepost-bw.jpg","type":"GRAPHIC","id":"NTFILEEbZdopJC18q5iqwf","market":"us","size":59818},{"description":"GRAPHIC","seq":49,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_prepostfollow-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_prepostfollow-bw.jpg","type":"GRAPHIC","id":"NTFILECHc2TB4N7iogbe3g","market":"us","size":46903},{"description":"GRAPHIC","seq":50,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_shortlong-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_shortlong-4c.jpg","type":"GRAPHIC","id":"NTFILEAQM7RBCQHEhGsrb4","market":"us","size":75791},{"description":"GRAPHIC","seq":51,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_tumar-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_tumar-4c.jpg","type":"GRAPHIC","id":"NTFILE7YD8LdYeusWCkfLi","market":"us","size":59489},{"description":"GRAPHIC","seq":52,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_tumarvalume-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_tumarvalume-4c.jpg","type":"GRAPHIC","id":"NTFILEEv6MSAkgt2eV15p6","market":"us","size":78429},{"description":"GRAPHIC","seq":53,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lc_tumorvolume-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_tumorvolume-4c.jpg","type":"GRAPHIC","id":"NTFILEAZoDjxWy4HconG48","market":"us","size":128548},{"description":"GRAPHIC","seq":54,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/lg_evaxion-bwlr.jpg","primary":false,"translateUrl":"","linkName":"lg_evaxion-bwlr.jpg","type":"GRAPHIC","id":"NTFILE4gmDHNGpRXsn9N9k","market":"us","size":12591},{"description":"GRAPHIC","seq":55,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/tb_diseasestage-4c.jpg","primary":false,"translateUrl":"","linkName":"tb_diseasestage-4c.jpg","type":"GRAPHIC","id":"NTFILEDSZzNAmYtMxTHHLr","market":"us","size":110882},{"description":"GRAPHIC","seq":56,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465925006720/tb_milestones-4c.jpg","primary":false,"translateUrl":"","linkName":"tb_milestones-4c.jpg","type":"GRAPHIC","id":"NTFILE2ABPdnLidkwHEch7","market":"us","size":106338}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2025-01-28 13:00","pubTimestamp":1738040400,"title_zh":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18955015","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924129424-EVAX","pdf_url":"","pub_time":1734473379000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","symbol":"EVAX","title":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1828253/0001104659-24-129424-index.html","us_notice_code":"Form F-1/A","us_title_en":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"F-1/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/tm2427973-5_f1a.htm","primary":true,"translateUrl":"","linkName":"tm2427973-5_f1a.htm","type":"F-1/A","id":"NTFILEHFbkVRVoHc8hjN2a","market":"us","size":2134845},{"description":"EXHIBIT 1.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/tm2427973d6_ex1-1.htm","primary":false,"translateUrl":"","linkName":"tm2427973d6_ex1-1.htm","type":"EX-1.1","id":"NTFILEGcr2aEFPELLo9FDg","market":"us","size":80940},{"description":"EXHIBIT 4.7","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/tm2427973d6_ex4-7.htm","primary":false,"translateUrl":"","linkName":"tm2427973d6_ex4-7.htm","type":"EX-4.7","id":"NTFILEDY7gQGux7xB5Fgs7","market":"us","size":94991},{"description":"EXHIBIT 4.8","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/tm2427973d6_ex4-8.htm","primary":false,"translateUrl":"","linkName":"tm2427973d6_ex4-8.htm","type":"EX-4.8","id":"NTFILEAFFbWrtXmzPeGx4L","market":"us","size":98903},{"description":"EXHIBIT 5.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/tm2427973d6_ex5-1.htm","primary":false,"translateUrl":"","linkName":"tm2427973d6_ex5-1.htm","type":"EX-5.1","id":"NTFILE9T3KZ9fk9no5qnsW","market":"us","size":49722},{"description":"EXHIBIT 10.18","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/tm2427973d6_ex10-18.htm","primary":false,"translateUrl":"","linkName":"tm2427973d6_ex10-18.htm","type":"EX-10.18","id":"NTFILEFEPaHPAMMTfe1qBQ","market":"us","size":206851},{"description":"EXHIBIT 23.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/tm2427973d6_ex23-1.htm","primary":false,"translateUrl":"","linkName":"tm2427973d6_ex23-1.htm","type":"EX-23.1","id":"NTFILE3AiNNh89CnzAupez","market":"us","size":2837},{"description":"EX-FILING FEES","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/tm2427973d6_ex-filingfees.htm","primary":false,"translateUrl":"","linkName":"tm2427973d6_ex-filingfees.htm","type":"EX-FILING FEES","id":"NTFILEuCbFY4PpuzS69Spn","market":"us","size":31190},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lg_evaxion-bwlr.jpg","primary":false,"translateUrl":"","linkName":"lg_evaxion-bwlr.jpg","type":"GRAPHIC","id":"NTFILEEedahQ2yDXCKcWB6","market":"us","size":12591},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_immun-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_immun-4c.jpg","type":"GRAPHIC","id":"NTFILEJ7giyNai96S8RZbf","market":"us","size":105452},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_strategy-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_strategy-4c.jpg","type":"GRAPHIC","id":"NTFILE4v6v9CgJXCiiJb4i","market":"us","size":132876},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/tb_milestones-4c.jpg","primary":false,"translateUrl":"","linkName":"tb_milestones-4c.jpg","type":"GRAPHIC","id":"NTFILE9pSBEYfJedksdrPG","market":"us","size":111477},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_aiimmunology-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_aiimmunology-4c.jpg","type":"GRAPHIC","id":"NTFILEAHiocjmeE6JNpVCx","market":"us","size":91703},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_cancer-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cancer-4c.jpg","type":"GRAPHIC","id":"NTFILEFrJDdUQPeih963ve","market":"us","size":60354},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_stageofdevelop-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_stageofdevelop-4c.jpg","type":"GRAPHIC","id":"NTFILE2Sbo6sahMnwmQjss","market":"us","size":92932},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_cells-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cells-4c.jpg","type":"GRAPHIC","id":"NTFILE662Lcmsnxz34aZSR","market":"us","size":51252},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/bc_bestranked-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_bestranked-4c.jpg","type":"GRAPHIC","id":"NTFILE7uRDv353hqMxxy6s","market":"us","size":36851},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_cellinoculation-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_cellinoculation-4c.jpg","type":"GRAPHIC","id":"NTFILE2wRy7dYtxi9nhSfr","market":"us","size":92243},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_pioneerrna-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_pioneerrna-4c.jpg","type":"GRAPHIC","id":"NTFILE7NAd7WdrvSiuYXtc","market":"us","size":52253},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_cancervaccines-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cancervaccines-4c.jpg","type":"GRAPHIC","id":"NTFILEiRtJXgQdrkAC2e4y","market":"us","size":42428},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_vaccinetreat-4clr.jpg","primary":false,"translateUrl":"","linkName":"fc_vaccinetreat-4clr.jpg","type":"GRAPHIC","id":"NTFILE8piueyXDVqPiogps","market":"us","size":96229},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/tb_diseasestage-4c.jpg","primary":false,"translateUrl":"","linkName":"tb_diseasestage-4c.jpg","type":"GRAPHIC","id":"NTFILE4HTd88TrBErAEj6K","market":"us","size":110882},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/bc_changetrg-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_changetrg-4c.jpg","type":"GRAPHIC","id":"NTFILE23LVACkMt6pZqNj3","market":"us","size":51187},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_prepost-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_prepost-bw.jpg","type":"GRAPHIC","id":"NTFILE9KEWt1J68Hdf6jU8","market":"us","size":59818},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_prepostfollow-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_prepostfollow-bw.jpg","type":"GRAPHIC","id":"NTFILEAYtPEbbFyGmJ1osN","market":"us","size":46903},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_pioneerscore-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_pioneerscore-bw.jpg","type":"GRAPHIC","id":"NTFILEGa1bDkUQ5ZkiuLcr","market":"us","size":45148},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_shortlong-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_shortlong-4c.jpg","type":"GRAPHIC","id":"NTFILEAXMpgKpewrsKwaHb","market":"us","size":75791},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_screening-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_screening-4c.jpg","type":"GRAPHIC","id":"NTFILEEBDZTkN8eFUjfJC9","market":"us","size":25983},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/bc_sfupbmc-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_sfupbmc-4c.jpg","type":"GRAPHIC","id":"NTFILEc7PNMXFKdqV8hQ6d","market":"us","size":83884},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_cd4cd8cells-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cd4cd8cells-4c.jpg","type":"GRAPHIC","id":"NTFILE9STWFyji9VjQBvpP","market":"us","size":74826},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_neoagspearson-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_neoagspearson-4c.jpg","type":"GRAPHIC","id":"NTFILEH9TZcPquhTuQr8L8","market":"us","size":70888},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/bc_patient-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_patient-4c.jpg","type":"GRAPHIC","id":"NTFILE2NBhf4fm87VM1SUu","market":"us","size":67682},{"description":"GRAPHIC","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/bc_preexisting-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_preexisting-4c.jpg","type":"GRAPHIC","id":"NTFILE7JWAhUuzKamR5kwu","market":"us","size":81117},{"description":"GRAPHIC","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_evx02-4clr.jpg","primary":false,"translateUrl":"","linkName":"fc_evx02-4clr.jpg","type":"GRAPHIC","id":"NTFILECwwfVreNPAoZwLFp","market":"us","size":95190},{"description":"GRAPHIC","seq":35,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_empty-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_empty-4c.jpg","type":"GRAPHIC","id":"NTFILEBM3puaeFFya1MvQZ","market":"us","size":35955},{"description":"GRAPHIC","seq":36,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_tumar-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_tumar-4c.jpg","type":"GRAPHIC","id":"NTFILEBN5KNUGcPbciN9FY","market":"us","size":59489},{"description":"GRAPHIC","seq":37,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_tumarvalume-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_tumarvalume-4c.jpg","type":"GRAPHIC","id":"NTFILE788qJBf5aXFbyMrF","market":"us","size":78429},{"description":"GRAPHIC","seq":38,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_emptyplasmid-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_emptyplasmid-4c.jpg","type":"GRAPHIC","id":"NTFILE2jNjhSrGFrnMYewa","market":"us","size":73045},{"description":"GRAPHIC","seq":39,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_tumorvolume-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_tumorvolume-4c.jpg","type":"GRAPHIC","id":"NTFILEFsfiuNvaUoQzJNhg","market":"us","size":128548},{"description":"GRAPHIC","seq":40,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_vehiclecontrol-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_vehiclecontrol-4c.jpg","type":"GRAPHIC","id":"NTFILE4D8Afnch9ewRHTL8","market":"us","size":135671},{"description":"GRAPHIC","seq":41,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_clinical-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_clinical-4c.jpg","type":"GRAPHIC","id":"NTFILEEA9E8Zdqd4YxrjtJ","market":"us","size":106643},{"description":"GRAPHIC","seq":42,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_liuhugoanti-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_liuhugoanti-4c.jpg","type":"GRAPHIC","id":"NTFILE8AGpJw97JH7mCTQ3","market":"us","size":155237},{"description":"GRAPHIC","seq":43,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_datacuration-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_datacuration-4c.jpg","type":"GRAPHIC","id":"NTFILEEDupg46d2JwxDQUj","market":"us","size":55331},{"description":"GRAPHIC","seq":44,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_discovery-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_discovery-4c.jpg","type":"GRAPHIC","id":"NTFILE9DUSESquJWHFg7Q3","market":"us","size":160498},{"description":"GRAPHIC","seq":45,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_bacteria-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_bacteria-4c.jpg","type":"GRAPHIC","id":"NTFILE3SQrUoRCjwzHfrJc","market":"us","size":154890},{"description":"GRAPHIC","seq":46,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_proteins-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_proteins-4c.jpg","type":"GRAPHIC","id":"NTFILEHFK9vZeg3XLGLwqt","market":"us","size":118887},{"description":"GRAPHIC","seq":47,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_evxb1-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_evxb1-4c.jpg","type":"GRAPHIC","id":"NTFILEDcPGrgTqiKamunmh","market":"us","size":62087},{"description":"GRAPHIC","seq":48,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_postinfection-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_postinfection-4c.jpg","type":"GRAPHIC","id":"NTFILE2wM7942j2eQz1ZNi","market":"us","size":22562},{"description":"GRAPHIC","seq":49,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_abcessarea-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_abcessarea-4c.jpg","type":"GRAPHIC","id":"NTFILEARwChL4UpRbBU1Js","market":"us","size":37776},{"description":"GRAPHIC","seq":50,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_halfmaxtiter-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_halfmaxtiter-4c.jpg","type":"GRAPHIC","id":"NTFILEJCDtBecyKYSCXvwn","market":"us","size":21103},{"description":"GRAPHIC","seq":51,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_kidneys-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_kidneys-4c.jpg","type":"GRAPHIC","id":"NTFILEB9dGonDHpXJot7PF","market":"us","size":24535},{"description":"GRAPHIC","seq":52,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_ngo265-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_ngo265-4c.jpg","type":"GRAPHIC","id":"NTFILE8dRMWGRuK4z24W1R","market":"us","size":174298},{"description":"GRAPHIC","seq":53,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_postinfections-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_postinfections-4c.jpg","type":"GRAPHIC","id":"NTFILE8vAabt89sFbWgWfK","market":"us","size":277722},{"description":"GRAPHIC","seq":54,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_auccfu-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_auccfu-4c.jpg","type":"GRAPHIC","id":"NTFILE4YrDyPfp3Y6wy8g7","market":"us","size":62059},{"description":"GRAPHIC","seq":55,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/lc_immunizations-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_immunizations-4c.jpg","type":"GRAPHIC","id":"NTFILE2PgiewTrBpEhXtZJ","market":"us","size":25560},{"description":"GRAPHIC","seq":56,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/bc_splenocytes-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_splenocytes-4c.jpg","type":"GRAPHIC","id":"NTFILE5GJKzBMHdkXCna9S","market":"us","size":38054},{"description":"GRAPHIC","seq":57,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/bc_killing-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_killing-4c.jpg","type":"GRAPHIC","id":"NTFILE7ZSY6QhnDRiA4o9R","market":"us","size":65238},{"description":"GRAPHIC","seq":58,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/fc_identification-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_identification-4c.jpg","type":"GRAPHIC","id":"NTFILEB49crWyd6jRCfPqG","market":"us","size":82717},{"description":"GRAPHIC","seq":59,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/bc_sarsgenome-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_sarsgenome-4c.jpg","type":"GRAPHIC","id":"NTFILE2drZ6h2ghWpubhRb","market":"us","size":38363},{"description":"GRAPHIC","seq":60,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/bc_antibody-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_antibody-4c.jpg","type":"GRAPHIC","id":"NTFILEENzy9ZnQHiu9WSwZ","market":"us","size":20090},{"description":"GRAPHIC","seq":61,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/tm2427973d4_ex5-1img001.jpg","primary":false,"translateUrl":"","linkName":"tm2427973d4_ex5-1img001.jpg","type":"GRAPHIC","id":"NTFILEJ82dznYiDmjurmKJ","market":"us","size":3052},{"description":"GRAPHIC","seq":62,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924129424/tm2427973d4_ex5-1img02.jpg","primary":false,"translateUrl":"","linkName":"tm2427973d4_ex5-1img02.jpg","type":"GRAPHIC","id":"NTFILE4eaC59QNBU8QL6Hp","market":"us","size":763}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2024-12-18 06:09","pubTimestamp":1734473379,"title_zh":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18912079","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924125931-EVAX","pdf_url":"","pub_time":1733374800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","symbol":"EVAX","title":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/0001104659-24-125931-index.htm","us_notice_code":"Form F-1/A","us_title_en":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"F-1/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tm2427973-3_f1a.htm","primary":true,"translateUrl":"","linkName":"tm2427973-3_f1a.htm","type":"F-1/A","id":"NTFILE8c6FTVHcaVamyC1F","market":"us","size":2125418},{"description":"EXHIBIT 1.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tm2427973d4_ex1-1.htm","primary":false,"translateUrl":"","linkName":"tm2427973d4_ex1-1.htm","type":"EX-1.1","id":"NTFILEGti8Zxxxy7R7mdRW","market":"us","size":80847},{"description":"EXHIBIT 4.7","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tm2427973d4_ex4-7.htm","primary":false,"translateUrl":"","linkName":"tm2427973d4_ex4-7.htm","type":"EX-4.7","id":"NTFILE8f3r31iKWgGzoUmM","market":"us","size":84482},{"description":"EXHIBIT 5.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tm2427973d4_ex5-1.htm","primary":false,"translateUrl":"","linkName":"tm2427973d4_ex5-1.htm","type":"EX-5.1","id":"NTFILE5AvGpmTftPychQZt","market":"us","size":47767},{"description":"EXHIBIT 8.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tm2427973d4_ex8-1.htm","primary":false,"translateUrl":"","linkName":"tm2427973d4_ex8-1.htm","type":"EX-8.1","id":"NTFILEQscBCUQER1FGQuW5","market":"us","size":25637},{"description":"EXHIBIT 10.18","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tm2427973d4_ex10-18.htm","primary":false,"translateUrl":"","linkName":"tm2427973d4_ex10-18.htm","type":"EX-10.18","id":"NTFILEGZUyq2bpGsUnkuWT","market":"us","size":204860},{"description":"EXHIBIT 23.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tm2427973d4_ex23-1.htm","primary":false,"translateUrl":"","linkName":"tm2427973d4_ex23-1.htm","type":"EX-23.1","id":"NTFILE6eX44cdPs5LBB5Ko","market":"us","size":2847},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/bc_antibody-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_antibody-4c.jpg","type":"GRAPHIC","id":"NTFILE7DJtam5fdRE7HxnZ","market":"us","size":20090},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/bc_bestranked-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_bestranked-4c.jpg","type":"GRAPHIC","id":"NTFILEGUQaRPkqtuKeBNpZ","market":"us","size":36851},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/bc_changetrg-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_changetrg-4c.jpg","type":"GRAPHIC","id":"NTFILEC9PmGwLGWs78TC74","market":"us","size":51187},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/bc_killing-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_killing-4c.jpg","type":"GRAPHIC","id":"NTFILE236CxfDigdPWX1uf","market":"us","size":65238},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/bc_patient-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_patient-4c.jpg","type":"GRAPHIC","id":"NTFILE2HMpSftCGwXpc81T","market":"us","size":67682},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/bc_preexisting-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_preexisting-4c.jpg","type":"GRAPHIC","id":"NTFILEFRFokxY7TLhCnqn2","market":"us","size":81117},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/bc_sarsgenome-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_sarsgenome-4c.jpg","type":"GRAPHIC","id":"NTFILE2LW3xVDB77zqiWDh","market":"us","size":38363},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/bc_sfupbmc-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_sfupbmc-4c.jpg","type":"GRAPHIC","id":"NTFILE3ozGSXHpVbAMM25h","market":"us","size":83884},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/bc_splenocytes-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_splenocytes-4c.jpg","type":"GRAPHIC","id":"NTFILEFbyMkkmTuVLVbegW","market":"us","size":38054},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_aiimmunology-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_aiimmunology-4c.jpg","type":"GRAPHIC","id":"NTFILE9Ln63BkWF18SghNY","market":"us","size":91703},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_cancer-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cancer-4c.jpg","type":"GRAPHIC","id":"NTFILEB2wRrjpRoi3vGv7R","market":"us","size":60354},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_cancervaccines-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cancervaccines-4c.jpg","type":"GRAPHIC","id":"NTFILEFqjqAxbpvivYa5QW","market":"us","size":42428},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_cd4cd8cells-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cd4cd8cells-4c.jpg","type":"GRAPHIC","id":"NTFILE8PpWSJZbW26HqV8L","market":"us","size":74826},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_cells-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cells-4c.jpg","type":"GRAPHIC","id":"NTFILEBXk9MRYoLAaWhCMe","market":"us","size":51252},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_datacuration-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_datacuration-4c.jpg","type":"GRAPHIC","id":"NTFILEHnEAc4nwMcV81H6z","market":"us","size":55331},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_discovery-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_discovery-4c.jpg","type":"GRAPHIC","id":"NTFILEDNFwZurDiV2QE5bv","market":"us","size":160498},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_evx02-4clr.jpg","primary":false,"translateUrl":"","linkName":"fc_evx02-4clr.jpg","type":"GRAPHIC","id":"NTFILEFnCkBeanz7eAqXHb","market":"us","size":95190},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_evxb1-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_evxb1-4c.jpg","type":"GRAPHIC","id":"NTFILE6CamTJfzp2yoejNo","market":"us","size":62087},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_identification-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_identification-4c.jpg","type":"GRAPHIC","id":"NTFILEHfHukemGFCHGy7XA","market":"us","size":82717},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_immun-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_immun-4c.jpg","type":"GRAPHIC","id":"NTFILE2GyewdzkBnL4Ho2E","market":"us","size":105452},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_ngo265-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_ngo265-4c.jpg","type":"GRAPHIC","id":"NTFILEA1PAGf6Y7Z12FNJs","market":"us","size":174298},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_pioneerrna-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_pioneerrna-4c.jpg","type":"GRAPHIC","id":"NTFILEFCY34TjLd4YLPy1A","market":"us","size":52253},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_proteins-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_proteins-4c.jpg","type":"GRAPHIC","id":"NTFILE3SfAQ7BKmB6TkPyu","market":"us","size":118887},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_screening-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_screening-4c.jpg","type":"GRAPHIC","id":"NTFILE25FnsBgv9RV3BQdP","market":"us","size":25983},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_stageofdevelop-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_stageofdevelop-4c.jpg","type":"GRAPHIC","id":"NTFILE7yoaFFQCMcpBYWfi","market":"us","size":92932},{"description":"GRAPHIC","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_strategy-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_strategy-4c.jpg","type":"GRAPHIC","id":"NTFILE6o8smKjMS118Y19n","market":"us","size":132876},{"description":"GRAPHIC","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_vaccinetreat-4clr.jpg","primary":false,"translateUrl":"","linkName":"fc_vaccinetreat-4clr.jpg","type":"GRAPHIC","id":"NTFILE73KXCRPGYQZrBhai","market":"us","size":96229},{"description":"GRAPHIC","seq":35,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/fc_vehiclecontrol-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_vehiclecontrol-4c.jpg","type":"GRAPHIC","id":"NTFILEjpsR4kjV9aueu6h2","market":"us","size":135671},{"description":"GRAPHIC","seq":36,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_abcessarea-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_abcessarea-4c.jpg","type":"GRAPHIC","id":"NTFILE7HNxmzo8CBDGc8Bh","market":"us","size":37776},{"description":"GRAPHIC","seq":37,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_auccfu-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_auccfu-4c.jpg","type":"GRAPHIC","id":"NTFILE3vuSPHoMmG5YUp21","market":"us","size":62059},{"description":"GRAPHIC","seq":38,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_bacteria-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_bacteria-4c.jpg","type":"GRAPHIC","id":"NTFILE8ccQMUNte2zkAowa","market":"us","size":154890},{"description":"GRAPHIC","seq":39,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_cellinoculation-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_cellinoculation-4c.jpg","type":"GRAPHIC","id":"NTFILEFCLfxS8nB8NNerzG","market":"us","size":92243},{"description":"GRAPHIC","seq":40,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_clinical-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_clinical-4c.jpg","type":"GRAPHIC","id":"NTFILEEShoTzNvmerN21Sr","market":"us","size":106643},{"description":"GRAPHIC","seq":41,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_empty-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_empty-4c.jpg","type":"GRAPHIC","id":"NTFILE4TDGddLsGTpwvjhi","market":"us","size":35955},{"description":"GRAPHIC","seq":42,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_emptyplasmid-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_emptyplasmid-4c.jpg","type":"GRAPHIC","id":"NTFILEGiez1mi3kSosp4oZ","market":"us","size":73045},{"description":"GRAPHIC","seq":43,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_halfmaxtiter-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_halfmaxtiter-4c.jpg","type":"GRAPHIC","id":"NTFILE2Y1Qqsq1kJw77z9U","market":"us","size":21103},{"description":"GRAPHIC","seq":44,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_immunizations-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_immunizations-4c.jpg","type":"GRAPHIC","id":"NTFILEG98WEiq7vVijwGpE","market":"us","size":25560},{"description":"GRAPHIC","seq":45,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_kidneys-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_kidneys-4c.jpg","type":"GRAPHIC","id":"NTFILECoakZq4ztY7wFH6R","market":"us","size":24535},{"description":"GRAPHIC","seq":46,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_liuhugoanti-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_liuhugoanti-4c.jpg","type":"GRAPHIC","id":"NTFILEDkZ9E9FdyEzkGPUq","market":"us","size":155237},{"description":"GRAPHIC","seq":47,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_neoagspearson-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_neoagspearson-4c.jpg","type":"GRAPHIC","id":"NTFILEB436J7gouSqRuno3","market":"us","size":70888},{"description":"GRAPHIC","seq":48,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_pioneerscore-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_pioneerscore-bw.jpg","type":"GRAPHIC","id":"NTFILEJ3jN8gmGLBnj3ij3","market":"us","size":45148},{"description":"GRAPHIC","seq":49,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_postinfection-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_postinfection-4c.jpg","type":"GRAPHIC","id":"NTFILEHSVALywNfHdpisRt","market":"us","size":22562},{"description":"GRAPHIC","seq":50,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_postinfections-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_postinfections-4c.jpg","type":"GRAPHIC","id":"NTFILEJ5HcNwSqR9VBftEo","market":"us","size":277722},{"description":"GRAPHIC","seq":51,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_prepost-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_prepost-bw.jpg","type":"GRAPHIC","id":"NTFILE7LERRT4W6DBFb9yb","market":"us","size":59818},{"description":"GRAPHIC","seq":52,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_prepostfollow-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_prepostfollow-bw.jpg","type":"GRAPHIC","id":"NTFILE2FwUGUuh2dp5aifg","market":"us","size":46903},{"description":"GRAPHIC","seq":53,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_shortlong-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_shortlong-4c.jpg","type":"GRAPHIC","id":"NTFILEFQZ4B7MSN2cg4DcZ","market":"us","size":75791},{"description":"GRAPHIC","seq":54,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_tumar-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_tumar-4c.jpg","type":"GRAPHIC","id":"NTFILE9xYjg1Fdtn7yBjLE","market":"us","size":59489},{"description":"GRAPHIC","seq":55,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_tumarvalume-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_tumarvalume-4c.jpg","type":"GRAPHIC","id":"NTFILEDcxtG7JhkmWZJt68","market":"us","size":78429},{"description":"GRAPHIC","seq":56,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lc_tumorvolume-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_tumorvolume-4c.jpg","type":"GRAPHIC","id":"NTFILEFW7Xzp2ymWPWekum","market":"us","size":128548},{"description":"GRAPHIC","seq":57,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/lg_evaxion-bwlr.jpg","primary":false,"translateUrl":"","linkName":"lg_evaxion-bwlr.jpg","type":"GRAPHIC","id":"NTFILEHsQsmvFG7cvjKfvH","market":"us","size":12591},{"description":"GRAPHIC","seq":58,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tb_diseasestage-4c.jpg","primary":false,"translateUrl":"","linkName":"tb_diseasestage-4c.jpg","type":"GRAPHIC","id":"NTFILE4ovVSMBaKwwJpLmU","market":"us","size":110882},{"description":"GRAPHIC","seq":59,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tb_milestones-4c.jpg","primary":false,"translateUrl":"","linkName":"tb_milestones-4c.jpg","type":"GRAPHIC","id":"NTFILE4JYakCidfreYgdpW","market":"us","size":111477},{"description":"GRAPHIC","seq":60,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tm2427973d4_ex5-1img001.jpg","primary":false,"translateUrl":"","linkName":"tm2427973d4_ex5-1img001.jpg","type":"GRAPHIC","id":"NTFILE8n5AFUQheayytaLT","market":"us","size":3052},{"description":"GRAPHIC","seq":61,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tm2427973d4_ex5-1img02.jpg","primary":false,"translateUrl":"","linkName":"tm2427973d4_ex5-1img02.jpg","type":"GRAPHIC","id":"NTFILEaS4JjaV6Prv3hrHm","market":"us","size":763},{"description":"GRAPHIC","seq":62,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tm2427973d4_ex8-1img001.jpg","primary":false,"translateUrl":"","linkName":"tm2427973d4_ex8-1img001.jpg","type":"GRAPHIC","id":"NTFILE3gJtdu1UZ72qQKcs","market":"us","size":3016},{"description":"GRAPHIC","seq":63,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924125931/tm2427973d4_ex8-1img002.jpg","primary":false,"translateUrl":"","linkName":"tm2427973d4_ex8-1img002.jpg","type":"GRAPHIC","id":"NTFILE6FqL4kGMop5PCcPW","market":"us","size":785}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2024-12-05 13:00","pubTimestamp":1733374800,"title_zh":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18847784","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924120159-EVAX","pdf_url":"","pub_time":1731906000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1 - Registration statement for certain foreign private issuers","symbol":"EVAX","title":"Form F-1 - Registration statement for certain foreign private issuers","titleType":"Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/0001104659-24-120159-index.htm","us_notice_code":"Form F-1","us_title_en":"Form F-1 - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"F-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/tm2427973-1_f1.htm","primary":true,"translateUrl":"","linkName":"tm2427973-1_f1.htm","type":"F-1","id":"NTFILE6vKcxBVCdTmz79mr","market":"us","size":2108146},{"description":"EXHIBIT 23.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/tm2427973d2_23-1.htm","primary":false,"translateUrl":"","linkName":"tm2427973d2_23-1.htm","type":"EX-23.1","id":"NTFILE9W3rgkemDkcM9qNv","market":"us","size":2067},{"description":"EX-FILING FEES","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/tm2427973d2_ex-filingfees.htm","primary":false,"translateUrl":"","linkName":"tm2427973d2_ex-filingfees.htm","type":"EX-FILING FEES","id":"NTFILE8wRf26b8Rq3iqaZU","market":"us","size":27517},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lg_evaxion-bwlr.jpg","primary":false,"translateUrl":"","linkName":"lg_evaxion-bwlr.jpg","type":"GRAPHIC","id":"NTFILEDmnvJX2qt1dfBLbR","market":"us","size":12591},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_immun-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_immun-4c.jpg","type":"GRAPHIC","id":"NTFILECssWTcFSdy9uTLHJ","market":"us","size":105452},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_strategy-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_strategy-4c.jpg","type":"GRAPHIC","id":"NTFILEAp6wKiENvgszmfHP","market":"us","size":132876},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/tb_milestones-4c.jpg","primary":false,"translateUrl":"","linkName":"tb_milestones-4c.jpg","type":"GRAPHIC","id":"NTFILE7D8xqcaTyowQJgxf","market":"us","size":111477},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_aiimmunology-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_aiimmunology-4c.jpg","type":"GRAPHIC","id":"NTFILEGSGVav2KHy4Si1gW","market":"us","size":91703},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_cancer-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cancer-4c.jpg","type":"GRAPHIC","id":"NTFILE2BHG5fH253J9KkKa","market":"us","size":60354},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_stageofdevelop-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_stageofdevelop-4c.jpg","type":"GRAPHIC","id":"NTFILE9e4rKun2g3UFUxaR","market":"us","size":92932},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_cells-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cells-4c.jpg","type":"GRAPHIC","id":"NTFILEGNbc41RqxnJvQMB6","market":"us","size":51252},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/bc_bestranked-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_bestranked-4c.jpg","type":"GRAPHIC","id":"NTFILEHD35eUmMm9AsSvMG","market":"us","size":36851},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_cellinoculation-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_cellinoculation-4c.jpg","type":"GRAPHIC","id":"NTFILE5ZtENtiTo6AraSzV","market":"us","size":92243},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_pioneerrna-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_pioneerrna-4c.jpg","type":"GRAPHIC","id":"NTFILEB92S58ZRRpfCfYb4","market":"us","size":52253},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_cancervaccines-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cancervaccines-4c.jpg","type":"GRAPHIC","id":"NTFILEDRWVBBmCnmbHfrzr","market":"us","size":42428},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_vaccinetreat-4clr.jpg","primary":false,"translateUrl":"","linkName":"fc_vaccinetreat-4clr.jpg","type":"GRAPHIC","id":"NTFILE4Mnb1hTdP8twTXJu","market":"us","size":96229},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/tb_diseasestage-4c.jpg","primary":false,"translateUrl":"","linkName":"tb_diseasestage-4c.jpg","type":"GRAPHIC","id":"NTFILE6aZgikt9jRUMyKef","market":"us","size":110882},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/bc_changetrg-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_changetrg-4c.jpg","type":"GRAPHIC","id":"NTFILE5ywbu8zeXdfBNUVx","market":"us","size":51187},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_prepost-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_prepost-bw.jpg","type":"GRAPHIC","id":"NTFILE3KZ7MGjwZMahvD1T","market":"us","size":59818},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_prepostfollow-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_prepostfollow-bw.jpg","type":"GRAPHIC","id":"NTFILE4tHnKtRcUoacvove","market":"us","size":46903},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_pioneerscore-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_pioneerscore-bw.jpg","type":"GRAPHIC","id":"NTFILE9PFG5pkhXG3hBaTY","market":"us","size":45148},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_shortlong-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_shortlong-4c.jpg","type":"GRAPHIC","id":"NTFILE6u8jCc25qMDYqb7c","market":"us","size":75791},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_screening-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_screening-4c.jpg","type":"GRAPHIC","id":"NTFILE75qVXYrgh9TuDfhj","market":"us","size":25983},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/bc_sfupbmc-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_sfupbmc-4c.jpg","type":"GRAPHIC","id":"NTFILEFumJkgb8cXhC2Ley","market":"us","size":83884},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_cd4cd8cells-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_cd4cd8cells-4c.jpg","type":"GRAPHIC","id":"NTFILE6GdTePDf4f7Mqycy","market":"us","size":74826},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_neoagspearson-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_neoagspearson-4c.jpg","type":"GRAPHIC","id":"NTFILEBJQLeMSQkxzSZHvL","market":"us","size":70888},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/bc_patient-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_patient-4c.jpg","type":"GRAPHIC","id":"NTFILEAocBRTM1Zekd4of7","market":"us","size":67682},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/bc_preexisting-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_preexisting-4c.jpg","type":"GRAPHIC","id":"NTFILE8MyASASewEBnE3qd","market":"us","size":81117},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_evx02-4clr.jpg","primary":false,"translateUrl":"","linkName":"fc_evx02-4clr.jpg","type":"GRAPHIC","id":"NTFILEHswPe8o9E5c2WzdA","market":"us","size":95190},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_empty-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_empty-4c.jpg","type":"GRAPHIC","id":"NTFILEHsnspFrDAzf1MMK1","market":"us","size":35955},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_tumar-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_tumar-4c.jpg","type":"GRAPHIC","id":"NTFILE143RKaKGzRNr5GrE","market":"us","size":59489},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_tumarvalume-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_tumarvalume-4c.jpg","type":"GRAPHIC","id":"NTFILE7D9KdTn5Kbn4RNLg","market":"us","size":78429},{"description":"GRAPHIC","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_emptyplasmid-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_emptyplasmid-4c.jpg","type":"GRAPHIC","id":"NTFILEG4SgtbGeYSQLnNRn","market":"us","size":73045},{"description":"GRAPHIC","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_tumorvolume-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_tumorvolume-4c.jpg","type":"GRAPHIC","id":"NTFILE6x6x8Y3iq66wwRRc","market":"us","size":128548},{"description":"GRAPHIC","seq":35,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_vehiclecontrol-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_vehiclecontrol-4c.jpg","type":"GRAPHIC","id":"NTFILECFGoujMEwpxJLRhU","market":"us","size":135671},{"description":"GRAPHIC","seq":36,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_clinical-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_clinical-4c.jpg","type":"GRAPHIC","id":"NTFILEA6zw4zbcXRHesBXQ","market":"us","size":106643},{"description":"GRAPHIC","seq":37,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_liuhugoanti-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_liuhugoanti-4c.jpg","type":"GRAPHIC","id":"NTFILE3HH5qwpc8jsVtU3D","market":"us","size":155237},{"description":"GRAPHIC","seq":38,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_datacuration-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_datacuration-4c.jpg","type":"GRAPHIC","id":"NTFILE6Z5cjZraki4Fk8ub","market":"us","size":55331},{"description":"GRAPHIC","seq":39,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_discovery-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_discovery-4c.jpg","type":"GRAPHIC","id":"NTFILE5Man5ykK9YUkUP6M","market":"us","size":160498},{"description":"GRAPHIC","seq":40,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_bacteria-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_bacteria-4c.jpg","type":"GRAPHIC","id":"NTFILE4FUF3JZdQELWygkv","market":"us","size":154890},{"description":"GRAPHIC","seq":41,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_proteins-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_proteins-4c.jpg","type":"GRAPHIC","id":"NTFILEFwAyPnzQFDqpyMSM","market":"us","size":118887},{"description":"GRAPHIC","seq":42,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_evxb1-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_evxb1-4c.jpg","type":"GRAPHIC","id":"NTFILEBbRWSVxmsgXY48aU","market":"us","size":62087},{"description":"GRAPHIC","seq":43,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_postinfection-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_postinfection-4c.jpg","type":"GRAPHIC","id":"NTFILEHrFz42sK1wAVpFsY","market":"us","size":22562},{"description":"GRAPHIC","seq":44,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_abcessarea-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_abcessarea-4c.jpg","type":"GRAPHIC","id":"NTFILEDrCbQB1uEtJvfhUw","market":"us","size":37776},{"description":"GRAPHIC","seq":45,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_halfmaxtiter-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_halfmaxtiter-4c.jpg","type":"GRAPHIC","id":"NTFILEFNbZnUDPjcugkxJR","market":"us","size":21103},{"description":"GRAPHIC","seq":46,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_kidneys-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_kidneys-4c.jpg","type":"GRAPHIC","id":"NTFILEG7u3F81kN72WSskY","market":"us","size":24535},{"description":"GRAPHIC","seq":47,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_ngo265-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_ngo265-4c.jpg","type":"GRAPHIC","id":"NTFILE6dwaUyH9VcSary8D","market":"us","size":174298},{"description":"GRAPHIC","seq":48,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_postinfections-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_postinfections-4c.jpg","type":"GRAPHIC","id":"NTFILEB868QThtNH84F2xE","market":"us","size":277722},{"description":"GRAPHIC","seq":49,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_auccfu-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_auccfu-4c.jpg","type":"GRAPHIC","id":"NTFILE5jS7Q4eMBs7tQzdL","market":"us","size":62059},{"description":"GRAPHIC","seq":50,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/lc_immunizations-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_immunizations-4c.jpg","type":"GRAPHIC","id":"NTFILEAmQ3m5Ysp6Wa6tA7","market":"us","size":25560},{"description":"GRAPHIC","seq":51,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/bc_splenocytes-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_splenocytes-4c.jpg","type":"GRAPHIC","id":"NTFILEDMpwtAy7Pco9Pf5a","market":"us","size":38054},{"description":"GRAPHIC","seq":52,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/bc_killing-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_killing-4c.jpg","type":"GRAPHIC","id":"NTFILE4npECrgkPZhDuHZz","market":"us","size":65238},{"description":"GRAPHIC","seq":53,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/fc_identification-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_identification-4c.jpg","type":"GRAPHIC","id":"NTFILEFqQgXWjMAY5UM2Pr","market":"us","size":82717},{"description":"GRAPHIC","seq":54,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/bc_sarsgenome-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_sarsgenome-4c.jpg","type":"GRAPHIC","id":"NTFILEC1uTD4uURFxgLkLG","market":"us","size":38363},{"description":"GRAPHIC","seq":55,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924120159/bc_antibody-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_antibody-4c.jpg","type":"GRAPHIC","id":"NTFILE5TzpuZ5TTz4Wc21a","market":"us","size":20090}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Public Prospectus","pubTime":"2024-11-18 13:00","pubTimestamp":1731906000,"title_zh":"Form F-1 - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18834979","market":"us","labels":[],"media":"sec.gov","original_id":"AN117266124005086-EVAX","pdf_url":"","pub_time":1731560400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G - Statement of Beneficial Ownership by Certain Investors","symbol":"EVAX","title":"Form SC 13G - Statement of Beneficial Ownership by Certain Investors","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1828253/000117266124005086/0001172661-24-005086-index.htm","us_notice_code":"Form SC 13G","us_title_en":"Form SC 13G - Statement of Beneficial Ownership by Certain Investors","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1601086/000117266124005086/armistice-evax093024.htm","primary":true,"translateUrl":"","linkName":"armistice-evax093024.htm","type":"SC 13G","id":"NTFILEEAGZBFTEnAE6WuQD","market":"us","size":88943}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2024-11-14 13:00","pubTimestamp":1731560400,"title_zh":"Form SC 13G - Statement of Beneficial Ownership by Certain Investors","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18804221","market":"us","labels":[],"media":"sec.gov","original_id":"AN89534524000536-EVAX","pdf_url":"","pub_time":1730927397000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"EVAX","title":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1828253/0000895345-24-000536-index.html","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/310158/000089534524000536/ff4087100_13ga1-evaxion.htm","primary":true,"translateUrl":"","linkName":"ff4087100_13ga1-evaxion.htm","type":"SC 13G/A","id":"NTFILE23yVTAfkoSYEopVV","market":"us","size":141041}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2024-11-07 05:09","pubTimestamp":1730927397,"title_zh":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18634495","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924091291-EVAX","pdf_url":"","pub_time":1724126400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"EVAX","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924091291/0001104659-24-091291-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924091291/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE7nnGGKYTi7iSQVhj","market":"us","size":9819},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924091291/tm2413457d8_correspimg001.jpg","primary":false,"translateUrl":"","linkName":"tm2413457d8_correspimg001.jpg","type":"GRAPHIC","id":"NTFILE3DN6Nj8mjagXE7p5","market":"us","size":10597}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2024-08-20 12:00","pubTimestamp":1724126400,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18494052","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924091081-EVAX","pdf_url":"","pub_time":1724126400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","symbol":"EVAX","title":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924091081/0001104659-24-091081-index.htm","us_notice_code":"Form F-1/A","us_title_en":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"F-1/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924091081/tm2413457-6_f1a.htm","primary":true,"translateUrl":"","linkName":"tm2413457-6_f1a.htm","type":"F-1/A","id":"NTFILEByREWwxpwbAmEB1F","market":"us","size":1113618},{"description":"EXHIBIT 23.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924091081/tm2413457d7_ex23-1.htm","primary":false,"translateUrl":"","linkName":"tm2413457d7_ex23-1.htm","type":"EX-23.1","id":"NTFILEEberbEKUBjNg88Mi","market":"us","size":2527},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924091081/lg_evaxionaiimmunology-bwlr.jpg","primary":false,"translateUrl":"","linkName":"lg_evaxionaiimmunology-bwlr.jpg","type":"GRAPHIC","id":"NTFILEBgFXmCS2ieFqcpgX","market":"us","size":10983},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924091081/tb_stageofdev-4clr.jpg","primary":false,"translateUrl":"","linkName":"tb_stageofdev-4clr.jpg","type":"GRAPHIC","id":"NTFILE7Dj72WjziHqh2eYH","market":"us","size":82669},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924091081/tb_screeningpembro-4clr.jpg","primary":false,"translateUrl":"","linkName":"tb_screeningpembro-4clr.jpg","type":"GRAPHIC","id":"NTFILE47WqoLygmeuuJY58","market":"us","size":31981},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924091081/tb_treatmentgroups-4clr.jpg","primary":false,"translateUrl":"","linkName":"tb_treatmentgroups-4clr.jpg","type":"GRAPHIC","id":"NTFILEJ13gw3R93SVjM9uW","market":"us","size":43283},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924091081/bc_ngstrains-4clr.jpg","primary":false,"translateUrl":"","linkName":"bc_ngstrains-4clr.jpg","type":"GRAPHIC","id":"NTFILE3Z5RUPqpBxE21XFJ","market":"us","size":61843}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2024-08-20 12:00","pubTimestamp":1724126400,"title_zh":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635050","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924081497-EVAX","pdf_url":"","pub_time":1721620800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"EVAX","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081497/0001104659-24-081497-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081497/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEBM4Agr6vSJ71RrRN","market":"us","size":20303},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081497/tm2413457d5_correspimg002.jpg","primary":false,"translateUrl":"","linkName":"tm2413457d5_correspimg002.jpg","type":"GRAPHIC","id":"NTFILE2bdkU2kGCiv4o5CG","market":"us","size":3170},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081497/tm2413457d5_correspimg001.jpg","primary":false,"translateUrl":"","linkName":"tm2413457d5_correspimg001.jpg","type":"GRAPHIC","id":"NTFILE9QkNsaGb1dbiaaxh","market":"us","size":7076}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2024-07-22 12:00","pubTimestamp":1721620800,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18392269","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924081492-EVAX","pdf_url":"","pub_time":1721620800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","symbol":"EVAX","title":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/0001104659-24-081492-index.htm","us_notice_code":"Form F-1/A","us_title_en":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"F-1/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/tm2413457-3_f1a.htm","primary":true,"translateUrl":"","linkName":"tm2413457-3_f1a.htm","type":"F-1/A","id":"NTFILE95bnFmcWjUs6Aqh7","market":"us","size":1103606},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/tm2413457d4_ex5-1.htm","primary":false,"translateUrl":"","linkName":"tm2413457d4_ex5-1.htm","type":"EX-5.1","id":"NTFILE3k2KFQaDTcGy9gXm","market":"us","size":39661},{"description":"EXHIBIT 8.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/tm2413457d4_ex8-1.htm","primary":false,"translateUrl":"","linkName":"tm2413457d4_ex8-1.htm","type":"EX-8.1","id":"NTFILE4y6oUWeTSsrzBk4z","market":"us","size":24155},{"description":"EXHIBIT 23.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/tm2413457d4_ex23-1.htm","primary":false,"translateUrl":"","linkName":"tm2413457d4_ex23-1.htm","type":"EX-23.1","id":"NTFILE45hB9PWikfUKXU2r","market":"us","size":2493},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/bc_ngstrains-4clr.jpg","primary":false,"translateUrl":"","linkName":"bc_ngstrains-4clr.jpg","type":"GRAPHIC","id":"NTFILEESZrQuK6L3HAYjU5","market":"us","size":61843},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/lg_evaxionaiimmunology-bwlr.jpg","primary":false,"translateUrl":"","linkName":"lg_evaxionaiimmunology-bwlr.jpg","type":"GRAPHIC","id":"NTFILE2Xo6zmxRHDRAMvyx","market":"us","size":10983},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/tb_screeningpembro-4clr.jpg","primary":false,"translateUrl":"","linkName":"tb_screeningpembro-4clr.jpg","type":"GRAPHIC","id":"NTFILEgJ3Z4K4W6a9Dwdb4","market":"us","size":31981},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/tb_stageofdev-4clr.jpg","primary":false,"translateUrl":"","linkName":"tb_stageofdev-4clr.jpg","type":"GRAPHIC","id":"NTFILE8k4oe6hMN2QD4dbT","market":"us","size":82669},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/tb_treatmentgroups-4clr.jpg","primary":false,"translateUrl":"","linkName":"tb_treatmentgroups-4clr.jpg","type":"GRAPHIC","id":"NTFILE5zqXu1ubCQPL3c9E","market":"us","size":43283},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEEAfp3nozsqUeWpMm","market":"us","size":7524},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/image_003.jpg","primary":false,"translateUrl":"","linkName":"image_003.jpg","type":"GRAPHIC","id":"NTFILEHfgATDtmEtmQEyb3","market":"us","size":1401},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924081492/image_002.jpg","primary":false,"translateUrl":"","linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILE5EMvic1KpiJ3zuG9","market":"us","size":2803}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2024-07-22 12:00","pubTimestamp":1721620800,"title_zh":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18104450","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924057512-EVAX","pdf_url":"","pub_time":1714968000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1 - Registration statement for certain foreign private issuers","symbol":"EVAX","title":"Form F-1 - Registration statement for certain foreign private issuers","titleType":"Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924057512/0001104659-24-057512-index.htm","us_notice_code":"Form F-1","us_title_en":"Form F-1 - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"FORM F-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924057512/tm2413457-1_f1.htm","primary":true,"translateUrl":"","linkName":"tm2413457-1_f1.htm","type":"F-1","id":"NTFILE4rWUqycDktFQxZ6t","market":"us","size":1044282},{"description":"EXHIBIT 23.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924057512/tm2413457d2_ex23-1.htm","primary":false,"translateUrl":"","linkName":"tm2413457d2_ex23-1.htm","type":"EX-23.1","id":"NTFILEHt8FWXTQQpm1DBLR","market":"us","size":2365},{"description":"EX-FILING FEES","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924057512/tm2413457d2_ex-filingfees.htm","primary":false,"translateUrl":"","linkName":"tm2413457d2_ex-filingfees.htm","type":"EX-FILING FEES","id":"NTFILEJ7FjwoexYDeEJLc7","market":"us","size":20307},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924057512/lg_evaxionaiimmunology-bwlr.jpg","primary":false,"translateUrl":"","linkName":"lg_evaxionaiimmunology-bwlr.jpg","type":"GRAPHIC","id":"NTFILEnxGEBHaWTFccBfEM","market":"us","size":10983}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Public Prospectus","pubTime":"2024-05-06 12:00","pubTimestamp":1714968000,"title_zh":"Form F-1 - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17756633","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924039004-EVAX","pdf_url":"","pub_time":1711425600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"EVAX","title":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/0001104659-24-039004-index.htm","us_notice_code":"Form 20-F","us_title_en":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"FORM 20-F","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f.htm","primary":true,"translateUrl":"","linkName":"evax-20231231x20f.htm","type":"20-F","id":"NTFILE8UQg6gkje8XpnEgq","market":"us","size":5890257},{"description":"EXHIBIT 12.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231xex12d1.htm","primary":false,"translateUrl":"","linkName":"evax-20231231xex12d1.htm","type":"EX-12.1","id":"NTFILE7djz569i81MmsFxf","market":"us","size":8021},{"description":"EXHIBIT 12.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231xex12d2.htm","primary":false,"translateUrl":"","linkName":"evax-20231231xex12d2.htm","type":"EX-12.2","id":"NTFILEDQYJZLZjPtUU8zXH","market":"us","size":8089},{"description":"EXHIBIT 13.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231xex13d1.htm","primary":false,"translateUrl":"","linkName":"evax-20231231xex13d1.htm","type":"EX-13.1","id":"NTFILE6x5qS7fdMXGdQWNk","market":"us","size":4559},{"description":"EXHIBIT 13.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231xex13d2.htm","primary":false,"translateUrl":"","linkName":"evax-20231231xex13d2.htm","type":"EX-13.2","id":"NTFILEAesHXGJusXY7AWh8","market":"us","size":5896},{"description":"EXHIBIT 15.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231xex15d1.htm","primary":false,"translateUrl":"","linkName":"evax-20231231xex15d1.htm","type":"EX-15.1","id":"NTFILE5hD5qYKu16enyMzM","market":"us","size":4168},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f005.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f005.jpg","type":"GRAPHIC","id":"NTFILEC8hR7VFVaRdYEAAf","market":"us","size":68727},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f006.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f006.jpg","type":"GRAPHIC","id":"NTFILE4SfT2VWTqsPMgrt2","market":"us","size":90328},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f007.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f007.jpg","type":"GRAPHIC","id":"NTFILEEuMAtbpkAi4JsJju","market":"us","size":57268},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f008.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f008.jpg","type":"GRAPHIC","id":"NTFILE7KNtEhEvubwLJ9Rb","market":"us","size":74551},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f009.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f009.jpg","type":"GRAPHIC","id":"NTFILE57976VL9JtGPtoQF","market":"us","size":66232},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f010.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f010.jpg","type":"GRAPHIC","id":"NTFILE7yvCPn95HNgFgg2A","market":"us","size":19671},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f011.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f011.jpg","type":"GRAPHIC","id":"NTFILE7vmQ8X9cqM8naKV2","market":"us","size":23408},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f012.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f012.jpg","type":"GRAPHIC","id":"NTFILEBxusQjUT8TkSJGBC","market":"us","size":24833},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f013.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f013.jpg","type":"GRAPHIC","id":"NTFILEGFx8qDwvgdEPAj6e","market":"us","size":22551},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f014.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f014.jpg","type":"GRAPHIC","id":"NTFILEdd18NmWcd7KUWsnf","market":"us","size":54866},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f015.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f015.jpg","type":"GRAPHIC","id":"NTFILEHT3nyPYywiLaQfHU","market":"us","size":41201},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f016.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f016.jpg","type":"GRAPHIC","id":"NTFILE6tqgzNpXjGgpCbAc","market":"us","size":62162},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f017.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f017.jpg","type":"GRAPHIC","id":"NTFILE6SSrK9ewSJm2Y6Rh","market":"us","size":34354},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f018.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f018.jpg","type":"GRAPHIC","id":"NTFILEGqHhFvKMYVYN6tNh","market":"us","size":36190},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f019.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f019.jpg","type":"GRAPHIC","id":"NTFILECHDmLUvt7wUGCCJP","market":"us","size":22053},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f020.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f020.jpg","type":"GRAPHIC","id":"NTFILE31bFbLG6kkMRLZ3N","market":"us","size":34608},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f021.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f021.jpg","type":"GRAPHIC","id":"NTFILE8PT5FhBGRqMMZaNx","market":"us","size":32954},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f022.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f022.jpg","type":"GRAPHIC","id":"NTFILEEsh1VnDw8RBKdWNJ","market":"us","size":51092},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f023.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f023.jpg","type":"GRAPHIC","id":"NTFILE4NmnwpgWSwT9UU8N","market":"us","size":17971},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f024.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f024.jpg","type":"GRAPHIC","id":"NTFILECxEV3zwGApKqgdqa","market":"us","size":47283},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f025.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f025.jpg","type":"GRAPHIC","id":"NTFILE58satjs6yRtTnYpZ","market":"us","size":27996},{"description":"GRAPHIC","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f026.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f026.jpg","type":"GRAPHIC","id":"NTFILE8PUsiP3i9fCAoCku","market":"us","size":20875},{"description":"GRAPHIC","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f027.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f027.jpg","type":"GRAPHIC","id":"NTFILEDmxTucy899wDkR5b","market":"us","size":50567},{"description":"GRAPHIC","seq":35,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f028.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f028.jpg","type":"GRAPHIC","id":"NTFILEAo1KAyMf7wY3CMSi","market":"us","size":55343},{"description":"GRAPHIC","seq":36,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f029.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f029.jpg","type":"GRAPHIC","id":"NTFILE3fJysUSk2xuAz5q2","market":"us","size":47452},{"description":"GRAPHIC","seq":37,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f030.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f030.jpg","type":"GRAPHIC","id":"NTFILEGdTAJxsGmjuutKhv","market":"us","size":28368},{"description":"GRAPHIC","seq":38,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f031.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f031.jpg","type":"GRAPHIC","id":"NTFILEDv2PsJm4teAXz8Py","market":"us","size":17994},{"description":"GRAPHIC","seq":39,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f032.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f032.jpg","type":"GRAPHIC","id":"NTFILEDRHouJWWj25C96mE","market":"us","size":47184},{"description":"GRAPHIC","seq":40,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f033.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f033.jpg","type":"GRAPHIC","id":"NTFILEpa32znKEkpKSsBNd","market":"us","size":37801},{"description":"GRAPHIC","seq":41,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f034.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f034.jpg","type":"GRAPHIC","id":"NTFILEA52x3ke42aJQ4KCn","market":"us","size":59408},{"description":"GRAPHIC","seq":42,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f035.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f035.jpg","type":"GRAPHIC","id":"NTFILE8BhQu4rcJbPtSBa5","market":"us","size":152335},{"description":"GRAPHIC","seq":43,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f036.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f036.jpg","type":"GRAPHIC","id":"NTFILE5F7VzgnBWFGXgu7q","market":"us","size":47812},{"description":"GRAPHIC","seq":44,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f037.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f037.jpg","type":"GRAPHIC","id":"NTFILE6rxCBqZy8gM2xgv9","market":"us","size":28163},{"description":"GRAPHIC","seq":45,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f038.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f038.jpg","type":"GRAPHIC","id":"NTFILEDdhWvgunn7M1yn9T","market":"us","size":16149},{"description":"GRAPHIC","seq":46,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f039.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f039.jpg","type":"GRAPHIC","id":"NTFILE9PxpsuKUS2zTjnkC","market":"us","size":20604},{"description":"GRAPHIC","seq":47,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f040.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f040.jpg","type":"GRAPHIC","id":"NTFILEBTnn2YyiHtH6NwSr","market":"us","size":18660},{"description":"GRAPHIC","seq":48,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f041.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f041.jpg","type":"GRAPHIC","id":"NTFILE9DgH34znnUUh34zq","market":"us","size":21734},{"description":"GRAPHIC","seq":49,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f042.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f042.jpg","type":"GRAPHIC","id":"NTFILE8FiC5MTP83eAn8K5","market":"us","size":21858},{"description":"GRAPHIC","seq":50,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f043.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f043.jpg","type":"GRAPHIC","id":"NTFILE78LBX1T7kERDzfNg","market":"us","size":52133},{"description":"GRAPHIC","seq":51,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f044.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f044.jpg","type":"GRAPHIC","id":"NTFILEGwmVY4wXLyDBTbEn","market":"us","size":30056},{"description":"GRAPHIC","seq":52,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f045.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f045.jpg","type":"GRAPHIC","id":"NTFILE8N3XeE62PhCoQ7AL","market":"us","size":18517},{"description":"GRAPHIC","seq":53,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f046.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f046.jpg","type":"GRAPHIC","id":"NTFILE8nL3ZxmcafirLViJ","market":"us","size":25282},{"description":"GRAPHIC","seq":54,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f047.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f047.jpg","type":"GRAPHIC","id":"NTFILEBoEfHSnUokSUojfv","market":"us","size":54754},{"description":"GRAPHIC","seq":55,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f048.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f048.jpg","type":"GRAPHIC","id":"NTFILEa8itUdp1Z9Z1p6TY","market":"us","size":47704},{"description":"GRAPHIC","seq":56,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f049.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f049.jpg","type":"GRAPHIC","id":"NTFILE9KoGbz5yQ7fd8Nvr","market":"us","size":30364},{"description":"GRAPHIC","seq":57,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924039004/evax-20231231x20f050.jpg","primary":false,"translateUrl":"","linkName":"evax-20231231x20f050.jpg","type":"GRAPHIC","id":"NTFILEDR9BywNaEXHcBfQ1","market":"us","size":11274}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Annual Report","pubTime":"2024-03-26 12:00","pubTimestamp":1711425600,"title_zh":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17540264","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924008874-EVAX","pdf_url":"","pub_time":1706677200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","symbol":"EVAX","title":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/0001104659-24-008874-index.htm","us_notice_code":"Form F-1/A","us_title_en":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"F-1/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/tm2334005-6_f1a.htm","primary":true,"translateUrl":"","linkName":"tm2334005-6_f1a.htm","type":"F-1/A","id":"NTFILE4GPFg5NUBfqCPz6W","market":"us","size":5743202},{"description":"EXHIBIT1.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/tm2334005d8_ex1-1.htm","primary":false,"translateUrl":"","linkName":"tm2334005d8_ex1-1.htm","type":"EX-1.1","id":"NTFILE7ZzrYjLS7zgHdeip","market":"us","size":87377},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/bc_fig13pioneer-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_fig13pioneer-4c.jpg","type":"GRAPHIC","id":"NTFILEHjVj2TfarW2dFfeo","market":"us","size":30201},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/bc_fig16stage-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_fig16stage-4c.jpg","type":"GRAPHIC","id":"NTFILEBs5eXw5YL5ygKCRC","market":"us","size":30594},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/bc_fig19lesions-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_fig19lesions-4c.jpg","type":"GRAPHIC","id":"NTFILEpoZWNxK3yt7EkyFE","market":"us","size":41911},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/bc_fig43kidneys-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_fig43kidneys-4c.jpg","type":"GRAPHIC","id":"NTFILE3ixFFVjBFaSKbfHQ","market":"us","size":25167},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/bc_fig47immunization-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_fig47immunization-4c.jpg","type":"GRAPHIC","id":"NTFILE38tbLADwcwn6sNd3","market":"us","size":26783},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/bc_fig48splenocytes-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_fig48splenocytes-4c.jpg","type":"GRAPHIC","id":"NTFILEER19ijVZqNDuA4e2","market":"us","size":35423},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/bc_fig49akilling-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_fig49akilling-4c.jpg","type":"GRAPHIC","id":"NTFILEVYhCyXAHHd3622WZ","market":"us","size":76748},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/bc_fig49killing-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_fig49killing-4c.jpg","type":"GRAPHIC","id":"NTFILE893SzYBeq8ehxTRf","market":"us","size":38699},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/bc_fig51tcellresponse-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_fig51tcellresponse-4c.jpg","type":"GRAPHIC","id":"NTFILEDPYEnRyDLBEgrqcY","market":"us","size":43939},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/bc_fig52antibody-4c.jpg","primary":false,"translateUrl":"","linkName":"bc_fig52antibody-4c.jpg","type":"GRAPHIC","id":"NTFILE9tmGTyKDr6y8J2qM","market":"us","size":22079},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/fc_fig03aiimmunolonew-4clr.jpg","primary":false,"translateUrl":"","linkName":"fc_fig03aiimmunolonew-4clr.jpg","type":"GRAPHIC","id":"NTFILEXTHpeEiNV9RTkLbk","market":"us","size":99521},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/fc_fig05stagedevelop-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_fig05stagedevelop-4c.jpg","type":"GRAPHIC","id":"NTFILEEyGzA66td7VvnfWG","market":"us","size":45718},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/fc_fig06ourstarat-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_fig06ourstarat-4c.jpg","type":"GRAPHIC","id":"NTFILE7qSiyr6hJ95ebvMB","market":"us","size":112297},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/fc_fig12cancer-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_fig12cancer-4c.jpg","type":"GRAPHIC","id":"NTFILEGvyMWcG3R96qWAV8","market":"us","size":43857},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/fc_fig15pioneer-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_fig15pioneer-4c.jpg","type":"GRAPHIC","id":"NTFILEC3potWDdeck5v1tQ","market":"us","size":42345},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/fc_fig17vaccine-4clr.jpg","primary":false,"translateUrl":"","linkName":"fc_fig17vaccine-4clr.jpg","type":"GRAPHIC","id":"NTFILEGp5tpvkYcjDDvUon","market":"us","size":82873},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/fc_fig24pembrolizumab-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_fig24pembrolizumab-4c.jpg","type":"GRAPHIC","id":"NTFILE9eVqjCsL5b9899qi","market":"us","size":21785},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/fc_fig36discovery-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_fig36discovery-4c.jpg","type":"GRAPHIC","id":"NTFILE8cgwCAptcEBVaM4E","market":"us","size":127689},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/fc_fig38eden-4clr.jpg","primary":false,"translateUrl":"","linkName":"fc_fig38eden-4clr.jpg","type":"GRAPHIC","id":"NTFILE2KNvnubQEtm9xyMQ","market":"us","size":115130},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/fc_fig39vaccine-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_fig39vaccine-4c.jpg","type":"GRAPHIC","id":"NTFILE3jzeLaJoTJMnhA2B","market":"us","size":56940},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/fc_fig44glase-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_fig44glase-4c.jpg","type":"GRAPHIC","id":"NTFILECgsFutgB8QwrwWdc","market":"us","size":119623},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/fc_fig50panproteome-4c.jpg","primary":false,"translateUrl":"","linkName":"fc_fig50panproteome-4c.jpg","type":"GRAPHIC","id":"NTFILE9RuRcsFVHkN9UEyb","market":"us","size":82816},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig14tumorvolum-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig14tumorvolum-4c.jpg","type":"GRAPHIC","id":"NTFILE48zdx77ejAWujxyX","market":"us","size":78226},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig20prepost-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_fig20prepost-bw.jpg","type":"GRAPHIC","id":"NTFILEGWedHZC3znSEvsV5","market":"us","size":55776},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig21prepostfollow-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_fig21prepostfollow-bw.jpg","type":"GRAPHIC","id":"NTFILECzWyf1ys7WTyqyUG","market":"us","size":44542},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig22mannwhitney-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_fig22mannwhitney-bw.jpg","type":"GRAPHIC","id":"NTFILE9x5jT5pZchW3Ps64","market":"us","size":42349},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig23neoantigen-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig23neoantigen-4c.jpg","type":"GRAPHIC","id":"NTFILE3JGjDKMrmypHp52S","market":"us","size":70709},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig27tumor-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig27tumor-4c.jpg","type":"GRAPHIC","id":"NTFILE6MXQTnbxFVPkW4rQ","market":"us","size":38500},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig28isotype-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig28isotype-4c.jpg","type":"GRAPHIC","id":"NTFILE62j2zxVgRUFZRsPk","market":"us","size":52750},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig29control-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig29control-4c.jpg","type":"GRAPHIC","id":"NTFILEBfztXcoNMKsFbA8W","market":"us","size":75360},{"description":"GRAPHIC","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig30inoculation-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig30inoculation-4c.jpg","type":"GRAPHIC","id":"NTFILECa13HKAR6evYKMMj","market":"us","size":69578},{"description":"GRAPHIC","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig31backbone-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig31backbone-4c.jpg","type":"GRAPHIC","id":"NTFILE8GWLqX39hgQU1M8U","market":"us","size":49275},{"description":"GRAPHIC","seq":35,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig33clinical-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_fig33clinical-bw.jpg","type":"GRAPHIC","id":"NTFILE9BJP1e3EU2HCqY81","market":"us","size":96970},{"description":"GRAPHIC","seq":36,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig34liuhugovan-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig34liuhugovan-4c.jpg","type":"GRAPHIC","id":"NTFILE3Bo5gyqKkrQLTEbd","market":"us","size":53554},{"description":"GRAPHIC","seq":37,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig37neisseria-bw.jpg","primary":false,"translateUrl":"","linkName":"lc_fig37neisseria-bw.jpg","type":"GRAPHIC","id":"NTFILE62i6sEy3hRP24swH","market":"us","size":142520},{"description":"GRAPHIC","seq":38,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig40evxb1-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig40evxb1-4c.jpg","type":"GRAPHIC","id":"NTFILEHF5nwSD8kBddawzY","market":"us","size":23812},{"description":"GRAPHIC","seq":39,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig41abcess-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig41abcess-4c.jpg","type":"GRAPHIC","id":"NTFILE3HTkyPbF33LRTqtq","market":"us","size":37370},{"description":"GRAPHIC","seq":40,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig42halfmax-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig42halfmax-4c.jpg","type":"GRAPHIC","id":"NTFILEASoiNZttVLSUtv5a","market":"us","size":21351},{"description":"GRAPHIC","seq":41,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig45evxb2-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig45evxb2-4c.jpg","type":"GRAPHIC","id":"NTFILEGvzh1PqgMzkbmFV8","market":"us","size":98294},{"description":"GRAPHIC","seq":42,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lc_fig46auclog-4c.jpg","primary":false,"translateUrl":"","linkName":"lc_fig46auclog-4c.jpg","type":"GRAPHIC","id":"NTFILEBMkQjRpHmBk3XaED","market":"us","size":63204},{"description":"GRAPHIC","seq":43,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/lg_evaxionaiimmunology-bwlr.jpg","primary":false,"translateUrl":"","linkName":"lg_evaxionaiimmunology-bwlr.jpg","type":"GRAPHIC","id":"NTFILE8DqjdwxYKVrMaTzZ","market":"us","size":10969},{"description":"GRAPHIC","seq":44,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/pc_fig04aiimmunolo-4c.jpg","primary":false,"translateUrl":"","linkName":"pc_fig04aiimmunolo-4c.jpg","type":"GRAPHIC","id":"NTFILE31WUjvrY2vVCnAjc","market":"us","size":57315},{"description":"GRAPHIC","seq":45,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/ph_fig25week-4c.jpg","primary":false,"translateUrl":"","linkName":"ph_fig25week-4c.jpg","type":"GRAPHIC","id":"NTFILEBX3ZtwWxEEPzxzVa","market":"us","size":117538},{"description":"GRAPHIC","seq":46,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/ph_fig26evx2evx3-4clr.jpg","primary":false,"translateUrl":"","linkName":"ph_fig26evx2evx3-4clr.jpg","type":"GRAPHIC","id":"NTFILE2jP9PeU2erpPB14Z","market":"us","size":78952},{"description":"GRAPHIC","seq":47,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/ph_fig35bacterial-4c.jpg","primary":false,"translateUrl":"","linkName":"ph_fig35bacterial-4c.jpg","type":"GRAPHIC","id":"NTFILE57K1mEnf58VQRUDj","market":"us","size":56165},{"description":"GRAPHIC","seq":48,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/tb_fig02milestones-4c.jpg","primary":false,"translateUrl":"","linkName":"tb_fig02milestones-4c.jpg","type":"GRAPHIC","id":"NTFILEGBtuBxXQntkH3vkZ","market":"us","size":67060},{"description":"GRAPHIC","seq":49,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/tb_fig18tumor-4c.jpg","primary":false,"translateUrl":"","linkName":"tb_fig18tumor-4c.jpg","type":"GRAPHIC","id":"NTFILEEcLW7Qqf6cav4pVe","market":"us","size":76653},{"description":"GRAPHIC","seq":50,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/tb_fig20trae-4clr.jpg","primary":false,"translateUrl":"","linkName":"tb_fig20trae-4clr.jpg","type":"GRAPHIC","id":"NTFILE32JGTvn1Fb8gSE8e","market":"us","size":21615},{"description":"GRAPHIC","seq":51,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/tb_fig32inoculatnew-4clr.jpg","primary":false,"translateUrl":"","linkName":"tb_fig32inoculatnew-4clr.jpg","type":"GRAPHIC","id":"NTFILEGqHQoQmtMNFF6qde","market":"us","size":45681},{"description":"GRAPHIC","seq":52,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/tm2334005d7_ex1-1img001.jpg","primary":false,"translateUrl":"","linkName":"tm2334005d7_ex1-1img001.jpg","type":"GRAPHIC","id":"NTFILE96e4aDcUZKaoAGdy","market":"us","size":7760},{"description":"GRAPHIC","seq":53,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1828253/000110465924008874/tm2334005d8_ex1-1aimg01.jpg","primary":false,"translateUrl":"","linkName":"tm2334005d8_ex1-1aimg01.jpg","type":"GRAPHIC","id":"NTFILEAoHvk4FrGmtokNEp","market":"us","size":8318}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2024-01-31 13:00","pubTimestamp":1706677200,"title_zh":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.evaxionbiotech.com","stockEarnings":[{"period":"1week","weight":-0.142},{"period":"1month","weight":-0.2216},{"period":"3month","weight":-0.6681},{"period":"6month","weight":-0.8976},{"period":"1year","weight":-0.9173},{"period":"ytd","weight":-0.6428}],"compareEarnings":[{"period":"1week","weight":-0.0907},{"period":"1month","weight":-0.1334},{"period":"3month","weight":-0.1464},{"period":"6month","weight":-0.1182},{"period":"1year","weight":-0.0152},{"period":"ytd","weight":-0.1379}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.307156},{"month":2,"riseRate":0,"avgChangeRate":-0.092268},{"month":3,"riseRate":0,"avgChangeRate":-0.116351},{"month":4,"riseRate":0.6,"avgChangeRate":0.07339},{"month":5,"riseRate":0.25,"avgChangeRate":-0.067063},{"month":6,"riseRate":0.25,"avgChangeRate":-0.055002},{"month":7,"riseRate":0.25,"avgChangeRate":0.052601},{"month":8,"riseRate":0.5,"avgChangeRate":-0.067943},{"month":9,"riseRate":1,"avgChangeRate":0.154645},{"month":10,"riseRate":0.25,"avgChangeRate":-0.004732},{"month":11,"riseRate":0,"avgChangeRate":-0.303517},{"month":12,"riseRate":0,"avgChangeRate":-0.217452}],"exchange":"NASDAQ","name":"Evaxion Biotech A/S","nameEN":"Evaxion Biotech A/S"},"aProfile":null}}}

Evaxion Biotech A/S(EVAX)

Company Profile